Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
((3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl sulfamate
-
-
(1R,2S,3S,4S)-4,6-diamino-2-([3-O-[(1S,2S,3S,4S,5S)-2-amino-5-(aminomethyl)-3,4-dihydroxycyclohexyl]-alpha-L-arabinofuranosyl]oxy)-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-beta-L-glucopyranoside
-
i.e. neosym
(2,4,6-triisopropylphenyl)sulfonylsulfamic acid
(2,4,6-tripropylphenyl)sulfonylsulfamic acid
(2,5-dichlorophenyl)sulfonylsulfamic acid
(2-nitrophenyl)sulfonylsulfamic acid
(2E)-2-[(4-hydroxy-3-methylphenyl)methylidene]-N-(5-sulfanylidene-4,5-dihydro-1,3,4-thiadiazol-2-yl)hydrazine-1-carboxamide
-
(2E)-2-[(4-hydroxyphenyl)methylidene]-N-(5-sulfanylidene-4,5-dihydro-1,3,4-thiadiazol-2-yl)hydrazine-1-carboxamide
-
(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid
-
(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid
-
(2E)-4-methoxy-4-oxobut-2-enoic acid
-
-
(2E)-but-2-enedioic acid
-
-
(2R)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-enoyl]amino]propanoic acid
-
-
(2S)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-enoyl]amino]propanoic acid
-
-
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
-
i.e. penokain G
-
(2Z)-2-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
(2Z)-2-(3-bromobenzylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
(2Z)-2-(3-methoxybenzylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
(2Z)-2-(4-chlorobenzylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
(2Z)-2-(4-fluorobenzylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(4-methylpentan-2-ylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
(2Z)-2-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
(2Z)-2-benzylidene-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
(3,5-dichloro-2-hydroxyphenyl)sulfonylsulfamic acid
(3-chloro-4-hydroxyphenyl)acetic acid
-
-
(3-chloro-4-nitrophenyl)sulfonylsulfamic acid
(3-chlorophenyl)(2-thioxo-1H-benzo[d]imidazol-1-yl)methanone
-
-
(3-chlorophenyl)acetic acid
-
-
(3-nitrophenyl)sulfonylsulfamic acid
(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl sulfamate
-
-
(4-acetylphenyl)sulfonylsulfamic acid
(4-bromophenyl)sulfonylsulfamic acid
(4-chlorophenyl)sulfonylsulfamic acid
(4-fluorophenyl)sulfonylsulfamic acid
(4-hydroxyphenyl)acetic acid
-
-
(4-iodophenyl)sulfonylsulfamic acid
(4-methoxyphenyl)sulfonylsulfamic acid
(4-methylphenyl)sulfonylsulfamic acid
(4-nitrophenyl)sulfonylsulfamic acid
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~-thieno[3,2-e][1,2]thiazine-6-sulfonamide
-
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda~6~-thieno[2,3-b]thiopyran-2-sulfonamide
-
(5Z)-2-amino-5-(3,4-dihydroxybenzylidene)-3,5-dihydro-4H-imidazol-4-one
-
-
(5Z)-2-amino-5-(4-hydroxy-3-methoxybenzylidene)-3,5-dihydro-4H-imidazol-4-one
-
-
(6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
-
-
(7S)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-[[(furan-2-carbonyl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
-
i.e. ceftiofur
(E)-3-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)prop-2-en-1-one
-
36% inhibition
(heptadecafluorooctyl)sulfonylsulfamic acid
(nonafluorobutyl)sulfonylsulfamic acid
(pentafluorophenyl)sulfonylsulfamic acid
(R)- 4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(R)- 4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(R)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one
-
(R)-17(R)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-carbonyl]benzene-1-sulfonamide
-
(R)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide
-
(R)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(R)-4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(R)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(R)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(R)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(R)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(R)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(R)-4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(R)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(R)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-sulfonamide
-
(R)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-sulfonamide
-
(R)-4-[4-(benzenesulfonyl)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide
-
(R)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide
-
(S)- 4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(S)- 4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(S)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one
-
(S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate
-
(S)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide
-
(S)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(S)-4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(S)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(S)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(S)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(S)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(S)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(S)-4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(S)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide
-
(S)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-sulfonamide
-
(S)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-carbonyl]benzene-1-sulfonamide
-
(S)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-sulfonamide
-
(S)-4-[4-(benzenesulfonyl)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide
-
(S)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide
-
(S)-benzyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-yl)carbamate
-
(S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate
-
(S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate
-
(S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate
-
(S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate
-
(S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate
-
(trichloromethyl)sulfonylsulfamic acid
(trifluoromethyl)sulfonylsulfamic acid
1,1'-(tribromo-lambda5-stibanediyl)bis(2-aminopyridin-1-ium)
1,1'-(tribromo-lambda5-stibanediyl)bis(2-aminopyrimidin-1-ium)
1,1'-(trichloro-lambda5-stibanediyl)bis(2-amino-4,6-dimethoxy-5-sulfanylpyrimidin-1-ium)
1,1'-(trichloro-lambda5-stibanediyl)bis(2-aminopyridin-1-ium)
1,1'-(trichloro-lambda5-stibanediyl)bis(2-aminopyrimidin-1-ium)
1,1'-(trichloro-lambda5-stibanediyl)bis[2-amino-4,6-dimethoxy-5-[(1H-tetrazol-5-yl)sulfanyl]pyrimidin-1-ium]
14.3% inhibition of CO2 hydration reaction after 30 min
1,1,1-trifluoromethanesulfonamide
-
1,1,2,2,3,3,4,4 octafluoro-n-butane-1-4-bissulfonamide
-
-
1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-n-hexane-1-sulfonamide
1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-n-heptane-1-sulfonamide
1,1,2,2,3,3,4,4-octafluoro-n-butane-1-4-bissulfonamide
-
-
1,1-dimethyl-4-(7-sulfamoyl-4H-[1,2,3]thiadiazolo[3,4-a]benzimidazol-3-yl)piperazin-1-ium iodide
-
1,2,4-trimethoxybenzene
-
-
1,2-benzothiazol-3(2H)-one 1,1-dioxide
1,2-bis[(2,4-dichloro-5-sulfonamidobenzamide)ethoxy]ethane
-
-
1,2-bis[(2,4-dichloro-5-sulfonamidobenzoate)-ethoxy]ethane
-
-
1,2-bis[(4-sulfonamidobenzamide)ethoxy]ethane
-
-
1,2-bis[(4-sulfonamidobenzoate)ethoxy]ethane
-
-
1,2:3,4-di-O-isopropylidene-alpha-D-galactopyranose 6-sulfamate
-
-
1,2:5,6-di-O-isopropylidene-alpha-D-glucofuranose 3-sulfamate
-
-
1,3-benzoxazole-2(3H)-thione
-
-
1,3-diacetyl-1H-benzo[d]imidazol-2(3H)-one
-
10% inhibition
1,3-diacetylbenzimidazole-2-thione
-
-
1,3-dihydro-2H-benzimidazole-2-thione
-
-
1,3-dimethylpyrimidine-2,4(1H,3H)-dione
inhibition of isozyme hCA I; inhibition of isozyme hCA II
1,3-dioxolan-2-yl-N-(2-propenyl)-2-thiophene-sulfonamide
-
-
1,5-bis[amino(dihydroxy)-lambda4-sulfanyl]-2,3-dichlorobenzene
1-(1,2-benzoxazol-3-yl)methanesulfonamide
1-(2-thioxo-1H-benzo[d]imidazol-1-yl)-3-phenylpropan-1-one
-
-
1-(2-thioxo-1H-benzo[d]imidazol-1-yl)ethanone
-
-
1-(2-thioxo-1H-benzo[d]imidazol-1-yl)hexan-1-one
-
-
1-(2-thioxo-1H-benzo[d]imidazol-1-yl)propan-1one
-
-
1-(2-thioxobenzo[d]oxazol-3(2H)-yl)decan-1-one
-
-
1-(2-thioxobenzo[d]oxazol-3(2H)-yl)ethanone
-
-
1-(2-thioxobenzo[d]oxazol-3(2H)-yl)hexadecan-1-one
-
-
1-(2-thioxobenzo[d]oxazol-3(2H)-yl)hexan-1-one
-
-
1-(2-thioxobenzo[d]oxazol-3(2H)-yl)propan-1-one
-
-
1-(2-Tthioxo-1H-benzo[d]imidazol-1-yl)butan-1-one
-
-
1-(3-acetyl-1,2-dihydro-2-thioxobenzo[d]imidazol-1-yl)hexan-1-one
-
-
1-(3-ethyl-1,2-dihydro-2-thioxobenzo[d]imidazole-1-yl)ethanone
-
-
1-(4-methoxyphenyl)-2-methyl-3-nitro-1-H-indol-6-ol
ID-8; ID-8
1-cyclohexyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide
-
1-cyclopentyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide
-
1-cyclopropyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide
-
1-ethyl-1H-benzo[d]imidazole-2(3H)-thione
-
28% inhibition
1-n-butyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide
-
1-naphthylsulfonylsulfamic acid
1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane
-
1-[(aminooxy)sulfinyl]-4-methylbenzene
-
-
1-[2-(1H-imidazol-5-yl)ethyl]-4-methyl-2,6-di(propan-2-yl)pyridin-1-ium hexafluorophosphate
-
1-[4-[(aminooxy)sulfinyl]phenyl]methanamine
-
-
1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]ethanamine
1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]methanamine
12,12,12-tribromo-7-oxo-6,7a,8,9,10,12-hexahydro-7H-12lambda5-pyrrolo[1',2':1,7][1,3,5,2]triazastibepino[4,3-b][1,3]benzothiazol-13-ium
1H,1H,2H,2H-perfluorodecyl sulfamate
-
-
1H,1H,2H,2H-perfluorooctyl sulfamate
-
-
1H,1H-perfluoroethyl sulfamate
-
-
1H-perfluoroisopropyl sulfamate
-
-
2,2,2-trifluoro-N-(4-sulfamoylphenyl)acetamide
-
-
2,3,4,5,6-pentafluoro-N-(2-sulfamoylphenyl)benzenesulfonamide
-
-
2,3,4,5,6-pentafluoro-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)benzamide
-
-
2,3,4,5,6-pentafluoro-N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]benzamide
-
-
2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-galactopyranosylamine
-
-
2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-glucopyranosylamine
-
-
2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-mannopyranosylamine
-
-
2,3,4-tri-O-acetyl-6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine
-
-
2,3,5,6-tetrafluoro-4-(2-phenylethanesulfonyl)benzene-1-sulfonamide
-
2,3,6-trifluoro-4-(2-hydroxyethanesulfonyl)-5-[[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]amino]benzene-1-sulfonamide
-
2,4,6-trichlorophenyl sulfamate
-
-
2,4-bis[(aminooxy)sulfinyl]-5-(trifluoromethyl)aniline
-
-
2,4-bis[(aminooxy)sulfinyl]-5-chloroaniline
-
-
2,4-bis[amino(dihydroxy)-lamba4-sulfanyl]-5-(trifluoromethyl)aniline
2,4-bis[amino(dihydroxy)-lambda4-sulfanyl]-5-chloroaniline
2,6-dimethoxybenzoic acid
-
-
2,6-PDCA
Halalkalibacterium halodurans
-
2-(1-methylethyl)-3-[(2-propynylamino)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-(1-methylethyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-(2,2-dichloroacetylamino)-1,3,4-thiadiazole-5-sulfonamide
-
noncompetitive inhibition
2-(2-hydroxyethyl)-N-(1,1-dimethylethyl)-2H-thieno[3,2-e-]-1,2-thiazine-6-sulfonamide 1,1-dioxide
-
-
2-(2-methoxyethyl)-3-[(4-morpholinyl)methyl]-2-(2-propenyl)-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-(2-methoxyethyl)-3-[[bis(2-methoxyethyl)amino]methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-(3,4-dimethoxyphenyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-(3-chloro-4-hydroxyphenyl)-N-(2-methoxyethyl)acetamide
-
-
2-(3-chloro-4-hydroxyphenyl)-N-(2-phenylethyl)acetamide
-
-
2-(3-chloro-4-hydroxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide
-
-
2-(3-chloro-4-hydroxyphenyl)-N-[2-(3-methoxyphenyl)ethyl]acetamide
-
-
2-(3-chloro-4-hydroxyphenyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide
-
-
2-(3-chloro-4-hydroxyphenyl)acetamide
-
-
2-(3-chloropropionylamino)-1,3,4-thiadiazole-5-sulfonamide
-
noncompetitive inhibition
2-(3-hydroxyphenyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-(3-hydroxyphenyl)-3-[(2-propynylamino)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-(3-hydroxyphenyl)ethyl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
-
2-(3-hydroxyphenyl)ethyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate
-
2-(3-hydroxypropyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-(3-methoxyphenyl)-3-[(2-hydroxyethylamino)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-(3-methoxyphenyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-(3-methoxypropyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-(3-methoxypropyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
2-(3-phenylpropionylamino)-1,3,4-thiadiazole-5-sulfonamide
-
noncompetitive inhibition
2-(4-hydroxyphenyl)acetamide
-
-
2-(4-hydroxyphenyl)ethyl (2E)-3-(3-hydroperoxy-4-hydroxyphenyl)prop-2-enoate
-
2-(4-hydroxyphenyl)ethyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate
-
2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(2-sulfamoylphenyl)acetamide
-
-
2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(3-sulfamoylphenyl)acetamide
-
-
2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(4-sulfamoylphenyl)acetamide
-
-
2-(benzenesulfonamido-N-benzyl)-5-[N,Ndibenzylsulfonamido]-l,3,4-thiadiazole
-
-
2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide
2-(hydroxymethyl)-4-nitro-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-sulfonamide
-
2-(hydroxymethyl)-4-nitro-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
2-(p-toluenesulfonamido)-l,3,4-thiadiazole-5-sulfonamide
-
-
2-(phenylethynyl)benzenesulfonamide
-
-
2-acetylamido-1,3,4-thiadiazole-5-sulfonamide
-
acetazolamide
2-adamantylethyl 7-methoxy-2-oxo-2H-chromene-8-carboxylate
-
-
2-amino-1-benzothiophen-3(2H)-one 1,1-dioxide
-
-
2-amino-pyrimidin-4-yl-sulfanilamide
-
best inhibitor
2-aminobenzenesulfonamide
2-benzene-sulfonamido-l,3,4-thiadiazole-5-sulfonamide
-
-
2-bromo-benzene sulfonamide
-
-
2-bromo-benzenesulfonamide
-
-
2-bromobenzene-1-sulfonamide
-
-
2-cyclohexyl-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-cyclopropylmethyl-3-[(4-morpholinyl)methyl]-2-(2-propenyl)-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-ethyl-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-ethyl-3-[[bis(2-hydroxyethyl)amino]methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-ethyl-3-[[bis(2-methoxyethyl)amino]methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-hydrazinobenzenesulfonamide
2-hydrazinylbenzenesulfonamide
2-hydroxycinnamic acid
-
-
2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide
2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-methanol 1,1-dioxide
-
-
2-methyl-2H-thieno[3,2-e]-1,2-thiazine-3-methanol 1,1-dioxide
-
-
2-methyl-3-(4-morpholinylmethyl)-2H-thieno[2,3-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide
-
-
2-methyl-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-methyl-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-methyl-3-[[N-(2-methoxyethyl)-N-(2-propenyl)amino]methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-methyl-3-[[N-(2-methoxyethyl)-N-(3-methoxypropyl)-amino]methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-methyl-N-(4-sulfamoylphenyl)propanamide
-
-
2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide
2-N-(4-sulfamoylphenyl)-thioformyl-L-Ala
-
-
2-N-(4-sulfamoylphenyl)-thioformyl-L-Asn
-
-
2-N-(4-sulfamoylphenyl)-thioformyl-L-Gln
-
-
2-N-(4-sulfamoylphenyl)-thioformyl-L-Ile
-
-
2-N-(4-sulfamoylphenyl)-thioformyl-L-Leu
-
-
2-N-(4-sulfamoylphenyl)-thioformyl-L-Met
-
-
2-N-(4-sulfamoylphenyl)-thioformyl-L-Phe
-
-
2-N-(4-sulfamoylphenyl)-thioformyl-L-Pro
-
-
2-N-(4-sulfamoylphenyl)-thioformyl-L-Trp
-
-
2-N-(4-sulfamoylphenyl)-thioformyl-L-Val
-
-
2-naphthylsulfonylsulfamic acid
2-nitrobenzenesulfonamide
-
-
2-Nitrophenol
-
product inhibition
2-oxo-2H-chromene-3-carboxylic acid
-
2-oxo-2H-thiochromene-3-carboxylic acid
-
2-oxo-N-(2-sulfamoylphenyl)-2H-chromene-3-carboxamide
-
-
2-oxo-N-(3-sulfamoylphenyl)-2H-chromene-3-carboxamide
-
-
2-oxo-N-(4-sulfamoylbenzyl)-2H-chromene-3-carboxamide
-
-
2-oxo-N-(4-sulfamoylphenyl)-2H-chromene-3-carboxamide
-
-
2-oxo-N-[2-(4-sulfamoylphenyl)ethyl]-2H-chromene-3-carboxamide
-
-
2-phenoxy-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)ethanone
-
-
2-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)ethanone
-
-
2-phenylethyl sulfamate
-
-
2-propyl-3-[(2-propynylamino)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-sulfonamido-1,3,4-thiadiazole-5-benzene sulfonamide
-
-
2-[(4-methoxyphenyl)methyl]-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
2-[(4-methoxyphenyl)methyl]-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-[(4-morpholinyl)phenyl]-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
2-[(aminooxy)sulfinyl]-5-(2-chlorophenyl)-1,3,4-thiadiazole
-
-
2-[(aminooxy)sulfinyl]aniline
-
-
2-[(diphenylcarbamoyl)amino]benzenesulfonamide
-
-
2-[(p-toluenesulfonamido)-N-methyl]-5-[N,N-dimethylsulfonamide]-l,3,4-thiadiazole
-
-
2-[2-(4-morpholinyl)ethyl]-2H-thieno[3,2-e-]-1,2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride
-
-
2-[2-(acetoxy)ethyl]-N-(1,1-dimethylethyl)-4-hydroxy-2H-thieno[3,2-e-]-1,2-thiazine-6-sulfonamide 1,1-dioxide
-
-
2-[2-(propylamino)ethyl]-2H-thieno[3,2-e-]-1,2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride
-
-
2-[2-[4-acetyl-(1-piperazinyl)]ethyl]-2H-thieno[3,2-e-]-1,2-thiazine-6-sulfonamide 1,1-dioxide
-
-
2-[2-[bis(2-methoxyethyl)amino]ethyl]-2H-thieno[3,2-e-]-1,2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride
-
-
2-[3-[2-(3-hydroxyphenyl)ethoxy]phenyl]ethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
-
2-[4-(4-morpholinyl)-2-butenyl]-2H-thieno[3,2-e-]-1,2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride
-
-
2-[4-[(aminooxy)sulfinyl]phenyl]ethanamine
-
-
2-[4-[(aminooxy)sulfinyl]phenyl]ethanol
-
-
2-[4-[2-(4-hydroxyphenyl)ethoxy]phenyl]ethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
-
2-[benzenesulfonamido-N-(n-propyl)]-l,3,4-thiadiazole-5-sulfonamide
-
-
2-[[(5-chlorothiophen-2-yl)(hydroxy)methyl]amino]-1-(trichloro[2-[2-(5-chlorothiophen-2-yl)-2-oxoethyl]pyrimidin-1-ium-1-yl]-lambda5-stibanyl)pyrimidin-1-ium
3,3,4,4,5,5,6,6,6-nonafluoro-n-hexanesulfonamide
3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-n-octanesulfonamide
3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-n-decanesulfonamide
3,3-dimethyl-N-(4-sulfamoylphenyl)butanamide
-
-
3,4,6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-arabino-hexopyranosylamine
-
-
3,4,6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-lyxo-hexopyranosylamine
-
-
3,4-dihydroisoquinoline-2(1H)-sulfonamide
-
3,4-dihydroxybenzoic acid
-
-
3,4-dimethoxybenzoic acid
-
-
3,5-dibromo-2-(1,3-dioxalan-2-yl)-thiophene
-
-
3,5-dichloro-2-hydroxybenzene-1-sulfonamide
-
3,5-dichloro-2-hydroxybenzenesulfonamide
3,5-Dihydroxybenzoic acid
-
-
3-(1,3-dioxolan-2-yl)-N-(2-methoxyethyl)-2-thiophenesulfonamide
-
-
3-(1,3-dioxolan-2-yl)-N-(3,4-dimethoxyphenyl)-2-thiophenesulfonamide
-
-
3-(1,3-dioxolan-2-yl)-N-(3-methoxyphenyl)-2-thiophenesulfonamide
-
-
3-(1,3-dioxolan-2-yl)-N-(4-(4-morpholinyl)phenyl)-2-thiophenesulfonamide
-
-
3-(1,3-dioxolan-2-yl)-N-cyclohexyl-2-thiophenesulfonamide
-
-
3-(1,3-dioxolan-2-yl)-N-[4-(4-morpholinyl)phenyl]-2-thiophenesulfonamide
-
-
3-(4-methylpiperazin-1-yl)-4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide
-
3-(4-sulfamoylphenyl)propanoic acid
3-(benzylamino)-2,5,6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide
-
3-(methylsulfanyl)-4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide
-
3-(methylsulfonyl)-4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide
-
3-(phenylethynyl)benzenesulfonamide
-
-
3-(phenylsulfanyl)-4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide
-
3-3-(1,3-dioxolan-2-yl)-N-(1-methylethyl)-2-thiophene-sulfonamide
-
-
3-acetylbenzo[d]oxazol-2(3H)-one
-
-
3-amino-1,1,1-tribromo-4,5-dihydro-1H-1lambda5-[1,3,5,2]triazastibinino[1,6-a]benzimidazol-10-ium
35% inhibition of CO2 hydration reaction after 30 min
3-amino-1,1,1-trichloro-4,5-dihydro-1H-1lambda5-[1,3,5,2]triazastibinino[1,6-a]benzimidazol-10-ium
10.0% inhibition of CO2 hydration reaction after 30 min
3-aminobenzene-1-sulfonamide
-
3-aminobenzenesulfonamide
3-bromo-4-amino-benzenesulfonamide
-
-
3-chloro-4-amino-benzenesulfonamide
-
-
3-chloro-4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide
-
3-chloromethyl-N-(1,1-dimethylethyl)-2-(3-methoxyphenyl)-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
3-chloropropyl sulfamate
-
-
3-cyclohexyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)propan-1-one
-
-
3-ethylbenzo[d]oxazole-2(3H)-thione
-
17% inhibition
3-fluoro-4-amino-benzenesulfonamide
-
-
3-hexanoylbenzo[d]oxazol-2(3H)-one
-
-
3-Hydroxybenzoic acid
-
-
3-hydroxymethyl 2-methyl-2H-thieno[2,3-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide
-
-
3-hydroxymethyl-2-methyl-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide
-
-
3-iodo-4-amino-benzenesulfonamide
-
-
3-methylphenylsulfamate
-
-
3-methylsalicylic acid
-
noncompetitive inhibition of isozyme carbonic anhydrase I and uncompetitive inhibition of isozyme carbonic anhydrase II
3-morpholin-4-yl-4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide
-
3-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)propan-1-one
-
-
3-phenylprop-2-ene-1-sulfonamide
-
-
3-phenylpropanenitrile
-
-
3-tributylgermylpropanamine
-
-
3-triethylgermylpropanamine
-
-
3-triethylsilylpropanamine
-
-
3-triphenylgermylpropanamine
-
-
3-[(1-imidazolyl)methyl]-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
3-[(3-fluorophenyl)ethynyl]benzenesulfonamide
-
-
3-[(3-methoxyphenyl)ethynyl]benzenesulfonamide
-
-
3-[(4-methylphenyl)ethynyl]benzenesulfonamide
-
-
3-[(4-morpholinyl)methyl]-2-(2-propenyl)-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
3-[(4-morpholinyl)methyl]-2-propyl-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
3-[(anilinocarbonyl)amino]benzenesulfonamide
3-[(cyclopropylamino)methyl]-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
3-[(phenylcarbamoyl)amino]benzenesulfonamide
-
-
3-[(sulfoamino)sulfonyl]benzoic acid
3-[1,3-dioxolan-2-yl]-N-(2-methoxyethyl)-2-thiophenesulfonamide
-
-
3-[1,3-dioxolan-2-yl]-N-(3,4-dimethoxyphenyl)-2-thiophenesulfonamide
-
-
3-[4-[(aminooxy)sulfinyl]phenyl]propanoic acid
-
-
3-[9-borabicyclo[1.3.3.]nonane]-1-bromopropane
-
-
3-[9-borabicyclo[1.3.3.]nonane]-1-propylsulfonic acid sodium salt
-
-
3-[amino(dihydroxy)-lambda4-sulfanyl]aniline
3-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-2,5,6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide
-
3-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-2,5,6-trifluoro-4-(2-phenylethanesulfonyl)benzene-1-sulfonamide
-
3-[[(3,4-dimethoxyphenyl)methyl]amino]-2,5,6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide
-
3-[[(aminosulfonyl)amino]sulfonyl]benzoic acid
3-[[bis(2-methoxyethyl)amino]methyl]-2-propyl-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
3-[[N-(2-methoxyethyl)-N-(2-propenyl)amino]methyl]-2-methyl-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
3-[[N-(2-methoxyethyl)-N-(3-methoxypropyl)amino]methyl]-2-methyl-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride
-
-
3-[[N-(2-methoxyethyl)-N-methylamino]methyl]-2-methyl-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
3alpha,12alpha-diacetoxy-5beta-cholan-24-oic acid
-
-
3alpha,7alpha,12alpha-triacetoxy-5beta-cholan-24-oic acid
-
-
3alpha-acetoxy-5beta-cholan-24-oic acid
-
-
4,4'-thiodipyridine-3-sulfonamide
-
-
4,4'-[(1R,2R,3S,4S)-3,4-dimethylcyclobutane-1,2-diyl]bis(2-methoxyphenol)
-
-
4,4'-[(1R,2S,3R,4S)-3,4-dimethylcyclobutane-1,2-diyl]bis(2-methoxyphenol)
-
-
4,4'-[(2R,3R)-2,3-dimethylbutane-1,4-diyl]bis(2-methoxyphenol)
-
-
4,5-dichloro-benzene-1,3-disulfonamide
4,5-dichlorobenzene-1,3-disulfonamide
4,6-dinitrosalicylic acid
-
noncompetitive inhibition of isozymes carbonic anhydrase I and II
4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide
4-(1,1-dioxo-1lambda6,2-thiazinan-2-yl)benzene-1-sulfonamide
-
4-(1,3,4-thiadiazol-2-ylthio)pyridine-3-sulfonamide
-
-
4-(1-methyl-5-tetrazolylthio)pyridine-3-sulfonamide
-
-
4-(2-([(4-sulfamoylphenyl)carbamothioyl]amino)ethyl)benzenesulfonamide
-
-
4-(2-amino-pyrimidin-4-yl)-benzenesulfonamide
4-(2-aminoethyl) benzenesulfonamide
-
-
4-(2-aminoethyl)benzene-1-sulfonamide
-
4-(2-aminoethyl)benzenesulfonamide
4-(2-hydroxyethyl)benzene-1-sulfonamide
-
4-(2-hydroxyethyl)benzenesulfonamide
4-(2-hydroxyethyl)phenol
-
-
4-(2-methyl-8-quinolinoxy)-3-pyridinesulfonamide
-
-
4-(2-methylphenyl)benzene-1-sulfonamide
-
4-(2-phenylacetamido)-3-bromobenzenesulfonamide
4-(2-phenylacetamido)-3-chlorobenzenesulfonamide
4-(2-phenylacetamido)-3-fluorobenzenesulfonamide
4-(2-phenylacetamido)benzenesulfonamide
4-(2-phenylacetamidoethyl)benzenesulfonamide
4-(2-phenylacetamidomethyl)benzenesulfonamide
4-(2-propynylthio)pyridine-3-sulfonamide
-
-
4-(2-pyridin-2-ylacetamido)benzenesulfonamide
4-(2-pyridin-4-ylacetamido)benzenesulfonamide
4-(2-pyridin-4-ylacetamidoethyl)benzenesulfonamide
4-(2-[(phenylcarbamothioyl)amino]ethyl)benzenesulfonamide
-
-
4-(2-[(phenylcarbamoyl)amino]ethyl)benzenesulfonamide
-
-
4-(3,4-dichlorophenylureido)thioureido-benzenesulfonamide
-
effective in vitro carbonic anhydrase inhibitor
4-(3-formylphenyl)benzene-1-sulfonamide
-
4-(3-quinolinyl)benzene-1-sulfonamide
-
4-(3-[[(1E)-(1-methyl-1H-imidazol-2-yl)methylidene]amino]propyl)benzenesulfonamide
-
-
4-(4'-dimethylaminophenyl)diazenylbenzenesulfonamide
-
-
4-(4'-hydroxyphenyl)diazenylbenzene-N,N-dimethylsulfonamide
-
-
4-(4'-hydroxyphenyl)diazenylbenzene-N-methylsulfonamide
-
-
4-(4'-hydroxyphenyl)diazenylbenzenesulfonamide
-
-
4-(4'-methoxyphenyl)diazenylbenzene-N,N-dimethylsulfonamide
-
-
4-(4-cyanophenoxy)-3-pyridinesulfonamide
-
-
4-(4-fluorophenoxy)-3-pyridinesulfonamide
-
-
4-(4-sulfanilyl-aminoethyl)-benzenesulfonamide
-
-
4-(4-sulfanilyl-aminomethyl)-benzenesulfonamide
-
-
4-(5-methyl-2-pyrazolino)-3-pyridinesulfonamide
-
-
4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide
-
4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
4-(6-nitrobenzothiazol-2-ylthio)pyridine-3-sulfonamide
-
-
4-(allylamino)-3-pyridinesulfonamide
-
-
4-(aminomethyl)benzene-1-sulfonamide
-
4-(aminomethyl)benzenesulfonamide
4-(aminosulfonyl)-N-[2-[4-(aminosulfonyl)phenyl]ethyl]benzamide
4-(aminosulfonyl)-N-{2-[4-(aminosulfonyl)phenyl]ethyl}benzamide
-
4-(aminosulfonyl)benzoic acid
4-(carbamothioylamino)benzenesulfonamide
-
-
4-(carbamoylmethylthio)pyridine-3-sulfonamide
-
-
4-(carboxyethyl)-benzenesulfonamide
-
-
4-(cyanomethylthio)pyridine-3-sulfonamide
-
-
4-(ethylamino)-6-(3-methoxypropyl)-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
-
-
4-(hydroxymethyl)benzene-1-sulfonamide
-
4-(hydroxymethyl)benzenesulfonamide
4-(methylhydrazino)-3-pyridinesulfonamide
-
-
4-(N-oxide-2-pyridylthio)pyridine-3-sulfonamide
-
-
4-(phenylethynyl)benzenesulfonamide
-
-
4-(quinolinoxy)-3-pyridinesulfonamide
-
-
4-([(1E)-[4-(dimethylamino)phenyl]methylidene]amino)benzenesulfonamide
-
-
4-([(phenylcarbamothioyl)amino]methyl)benzenesulfonamide
-
-
4-([[(1Z)-(2-chlorophenyl)methylidene]amino]methyl)benzenesulfonamide
-
-
4-([[(diethyl-l5-azanylidyne)methyl]disulfanyl]amino)benzenesulfonamide
-
-
4-acetyl-N-(aminosulfonyl)benzenesulfonamide
4-acetylamidophenyl sulfamate
-
-
4-amino-3,5-dibromobenzenesulfonamide
4-amino-3,5-diiodobenzenesulfonamide
4-amino-3,bromobenzenesulfonamide
-
-
4-amino-3-bromobenzene-1-sulfonamide
-
4-amino-3-bromobenzenesulfonamide
4-amino-3-chlorobenzene-1-sulfonamide
-
4-amino-3-chlorobenzenesulfonamide
4-amino-3-fluoro-5-iodobenzenesulfonamide
-
4-amino-3-fluorobenzene-1-sulfonamide
-
4-amino-3-fluorobenzenesulfonamide
4-amino-3-iodobenzenesulfonamide
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
4-amino-6-chloro-1-3 benzenedisulfonamide
-
-
4-amino-6-chloro-benzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
4-amino-6-trifluoromethyl-benzene-1,3-disulfonamide
-
-
4-amino-benzenesulfonamide
-
-
4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzene-1-sulfonamide
-
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
4-amino-N-(4-sulfamoylcyclopenta-1,3-dien-1-yl)benzene-1-sulfonamide
-
4-amino-N-(4-sulfamoylphenyl)benzene-1-sulfonamide
-
4-amino-N-(4-sulfamoylphenyl)benzenesulfonamide
4-amino-N-(pyrimidin-2-yl)benzene-1-sulfonamide
-
-
4-amino-N-carbamimidoylbenzene-1-sulfonamide
-
-
4-amino-N-[(4-sulfamoylphenyl)methyl]benzene-1-sulfonamide
-
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-sulfonamide
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
4-amino-N-[4-(aminosulfonyl)benzyl]benzenesulfonamide
4-amino-N-[4-[(aminooxy)sulfinyl]benzyl]benzenesulfonamide
-
-
4-amino-N-{2-[4-(aminosulfonyl)phenyl]ethyl}benzenesulfonamide
4-aminobenzene-1-sulfonamide
-
4-Aminobenzenesulfonamide
4-aminoethyl-benzenesulfonamide
4-aminoethylbenzenesulfonamide
-
4-aminomethyl-benzenesulfonamide
-
-
4-aminosalicylic acid
-
noncompetitive inhibition of isozymes carbonic anhydrase I and II
4-benzythiopyridine-3-sulfonamide
-
-
4-bromo-5-(1,3-dioxalan-2-yl)-N-(1,1-dimethylethyl)-thiophene-2-sulfonamide
-
-
4-bromobenzenesulfonamide
4-carboxy-benzenesulfonamide
-
-
4-chloro-6-[(phenylcarbamoyl)amino]benzene-1,3-disulfonamide
-
-
4-chlorobenzene sulfonamide
-
-
4-chlorobenzene-1-sulfonamide
-
-
4-chlorobenzenesulfonamide
-
-
4-cyanophenyl sulfamate
-
-
4-ethoxy-3-pyridinesulfonamide
-
-
4-ethynylbenzenesulfonamide
-
-
4-fluorobenzenesulfonamide
-
4-hydrazino-3-pyridinesulfonamide
-
-
4-hydrazinobenzenesulfonamide
4-hydrazinylbenzenesulfonamide
4-hydroxybenzene-1-sulfonamide
-
4-hydroxybenzenesulfonamide
4-hydroxybenzoic acid
-
-
4-Hydroxybenzonitrile
-
-
4-hydroxyethyl-benzenesulfonamide
-
-
4-hydroxymethyl-benzenesulfonamide
-
-
4-iodophenyl sulfamate
-
-
4-methoxy-3-pyridinesulfonamide
-
-
4-methoxyphenyl sulfamate
-
-
4-methyl-5-imino-1,3,4-thiadiazoline-2-sulfonamide
-
-
4-methyl-benzenesulfonamide
-
-
4-methylbenzene-1-sulfonamide
4-methylbenzenesulfonamide
4-methylphenyl sulfamate
-
-
4-methylthiopyridine-3-sulfonamide
-
-
4-nitrobenzenesulfonamide
-
-
4-nitrophenyl sulfamate
-
-
4-phenoxyphenyl sulfamate
-
-
4-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)butan-1-one
-
-
4-phenylbenzene-1-sulfonamide
-
4-phenylphenyl sulfamate
-
-
4-S-isobutylamino-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
-
binds 800 times more strongly to carbonic anhydrase II than to carbonic anhydrase I
4-sulfamoyl-N-(4-sulfamoylphenyl)benzamide
-
-
4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide
4-sulfosalicylic acid
-
uncompetitive inhibition of isozyme carbonic anhydrase I and competitive inhibition of isozyme carbonic anhydrase II
4-t-butylphenyl sulfamate
-
-
4-trichloromethylphenyl sulfamate
-
-
4-[(2-aminopyrimidin-4-yl)amino]benzene-1-sulfonamide
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
4-[(2R)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide
-
4-[(2S)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide
-
4-[(3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)amino]benzenesulfonamide
-
4-[(3-fluorophenyl)ethynyl]benzenesulfonamide
-
-
4-[(3-hydroxyphenyl)ethynyl]benzenesulfonamide
-
-
4-[(3-methoxyphenyl)ethynyl]benzenesulfonamide
-
-
4-[(4-methylphenyl)ethynyl]benzenesulfonamide
-
-
4-[(acetyloxy)amino]-N-[4-(aminosulfonyl)phenyl]benzenesulfonamide
4-[(aminooxy)sulfinyl]-2-bromoaniline
-
-
4-[(aminooxy)sulfinyl]-2-chloroaniline
-
-
4-[(aminooxy)sulfinyl]-2-fluoroaniline
-
-
4-[(aminooxy)sulfinyl]-2-iodoaniline
-
-
4-[(aminooxy)sulfinyl]aniline
-
-
4-[(aminooxy)sulfinyl]benzoic acid
-
-
4-[(anilinocarbonyl)amino]-6-chlorobenzene-1,3-disulfonamide
4-[(methylsulfonyl)amino]benzenesulfonamide
4-[(phenylsulfonyl)amino]benzenesulfonamide
4-[(sulfoamino)sulfonyl]benzoic acid
4-[([(1Z)-[4-(dimethylamino)phenyl]methylidene]amino)methyl]benzenesulfonamide
-
-
4-[([[(diethyl-l5-azanylidyne)methyl]disulfanyl]amino)methyl]benzenesulfonamide
-
-
4-[2-(2-thienyl)acetamidoethyl]benzenesulfonamide
4-[2-(2-thienyl)acetamidomethyl]benzenesulfonamide
4-[2-(2-thienyl)acetamido]-3-bromobenzenesulfonamide
4-[2-(2-thienyl)acetamido]-3-chlorobenzenesulfonamide
4-[2-(2-thienyl)acetamido]-3-fluorobenzenesulfonamide
4-[2-(2-thienyl)acetamido]benzenesulfonamide
4-[2-(4-sulfamoylphenyl)ethylamino]-3-pyridinosulfonamide
-
-
4-[2-[(2-oxo-2H-chromen-3-yl)carbonyl]hydrazino]benzenesulfonamide
-
-
4-[2-[(7-methoxy-2-oxo-2H-chromen-4-yl)acetyl]hydrazino]benzenesulfonamide
-
-
4-[2-[(anilinocarbonothioyl)amino]ethyl]benzenesulfonamide
4-[2-[(anilinocarbonyl)amino]ethyl]benzenesulfonamide
4-[2-[([[4-(aminosulfonyl)phenyl]amino]carbonothioyl)amino]ethyl]benzenesulfonamide
4-[3-([(1E)-[4-(dimethylamino)phenyl]methylidene]amino)propyl]benzenesulfonamide
-
-
4-[4-(aminosulfonyl)phenyl]-1-(2',3',4',6'-tetra-O-acetyl-alpha-D-mannopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(2',3',4',6'-tetra-O-acetyl-beta-D-galactopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(2',3',4',6'-tetra-O-acetyl-beta-D-glucopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(2',3',4'-tri-O-acetyl-alpha-D-arabinopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(2',3',4'-tri-O-acetyl-beta-D-glucuronic acid methyl ester)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(2',3',5'-tri-O-benzoyl-beta-D-ribofuranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(2'-acetamido-2'-deoxy'-3',4',6'-tri-O-acetyl-beta-D-glucopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(2'-acetamido-2'-deoxy-beta-D-glucopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(alpha-D-arabinopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(alpha-D-mannopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(beta-D-galactopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(beta-D-glucopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(beta-D-glucuronic acid methyl ester)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(beta-D-maltopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(beta-D-ribofuranosyl)-1H-1,2,3-triazole
-
-
4-[4-(aminosulfonyl)phenyl]-1-(hepta-O-acetyl-beta-D-maltopyranosyl)-1H-1,2,3-triazole
-
-
4-[4-(methylsulfonyl)phenyl]-3-phenyldihydrofuran-2(3H)-one
-
-
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-bromoaniline
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-chloroaniline
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-fluoroaniline
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-iodoaniline
4-[cis-5-norbornene-endo-2,3-dicarboximidoethyl]-benzenesulfonamide
-
-
4-[cis-5-norbornene-endo-2,3-dicarboximidomethyl]-benzenesulfonamide
-
-
4-[cis-5-norbornene-endo-2,3-dicarboximido]-benzenesulfonamide
-
-
4-[cis-5-norbornene-endo-3-carboxy-2-carboxamidoethyl]-benzenesulfonamide
-
-
4-[cis-5-norbornene-endo-3-carboxy-2-carboxamidomethyl]-benzenesulfonamide
-
-
4-[cis-5-norbornene-endo-3-carboxy-2-carboxamido]-benzenesulfonamide
-
-
4-[N'-(1,1-dioxopyrido[4,3-e]-1,4,2-dithiazin-3-yl)hydrazino]-3-pyridinesulfonamide
-
-
4-[N'-(6-chloro-7-cyano-1,1-dioxo-1,4,2-benzodithiazin-3-yl)hydrazino]-3-pyridinesulfonamide
-
-
4-[N'-(6-chloro-7-methyl-1,1-dioxo-1,4,2-benzodithiazin-3-yl)hydrazino]-3-pyridinesulfonamide
-
-
4-[[(1Z)-(1-bromonaphthalen-2-yl)methylidene]amino]benzenesulfonamide
-
-
4-[[(2R,3R)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide
-
4-[[(2R,5S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide
-
4-[[(3,4-dichlorophenyl)carbamoyl]amino]benzenesulfonamide
-
-
4-[[(3R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide
-
4-[[(3R,4R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide
-
4-[[(4R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide
-
4-[[(5R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide
-
4-[[(aminosulfonyl)amino]sulfonyl]benzoic acid
4-[[(anilinocarbonothioyl)amino]methyl]benzenesulfonamide
4-[[(diphenylcarbamoyl)amino]methyl]benzenesulfonamide
-
-
4-[[(phenylsulfonyl)amino]methyl]benzenesulfonamide
4-[[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide
-
4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide
-
5,5,5-tribromo-1,2,3,7,8,9,9a,11,16,17a-decahydro-5H-5lambda5-dipyrrolo[2,1-c:1',2'-f][1,4,6,9,5]benzotetraazastibacycloundecine-10,17-dione
5,6-diamino-1,3-dimethyluracil
inhibition of isozyme hCA I; inhibition of isozyme hCA II
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
5-(2-phenylacetamido)-1,3,4-thiadiazole-2-sulfonamide
5-(3,7,12-trioxo-5beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(3-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
5-(3alpha,12alpha-dihydroxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(3alpha,12alpha-dihydroxy-5beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(3alpha,7alpha,12alpha-triacetoxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(3alpha,7alpha,12alpha-triacetoxy-5beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(3alpha,7alpha,12alpha-trihydroxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(3alpha,7alpha,12alpha-trihydroxy-5beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(3alpha-acetoxy-5beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(3alpha-hydroxy-5beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(formylamino)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione
inhibition of isozyme hCA I
5-([(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-([(4-aminophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide
5-([(4-bromophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-([(4-nitrophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-acetamido-1,3,4-thiadiazole-2-sulfonamide
5-amino-1,3,4-thiadiazole-2-sulfonamide
5-bromo-1-(4-methylbenzene-1-sulfonyl)pyrimidine-2,4(1H,3H)-dione
inhibition of isozyme hCA I; inhibition of isozyme hCA II
5-bromo-1-(methanesulfonyl)pyrimidine-2,4(1H,3H)-dione
inhibition of isozyme hCA I; inhibition of isozyme hCA II
5-chlorosalicylic acid
-
uncompetitive inhibition of isozymes carbonic anhydrase I and II
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
5-pentylresorcinylsulfamate
-
-
5-sulfosalicylic acid
-
competitive inhibition of isozyme carbonic anhydrase I and noncompetitive inhibition of isozyme carbonic anhydrase II
5-[(2-phenylethyl)(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(aminooxy)sulfinyl]-1,3,4-thiadiazol-2-amine
-
-
5-[(aminooxy)sulfinyl]-3-methyl-1,3,4-thiadiazol-2(3H)-imine
-
-
5-[(benzenesulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
5-[(benzylsulfonyl)(2,4-dichlorobenzyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(benzylsulfonyl)(2-methylpropyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(benzylsulfonyl)(3,4,5-trimethoxybenzyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(benzylsulfonyl)(4-chlorobenzyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(benzylsulfonyl)(4-methoxybenzyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(benzylsulfonyl)(butyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(benzylsulfonyl)(dodecyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(benzylsulfonyl)(pentyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(benzylsulfonyl)(propan-2-yl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
5-[2-(2-thienyl)acetamido]-1,3,4-thiadiazole-2-sulfonamide
5-[benzyl(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[cis-5-norbornene-endo-2,3-dicarboximido]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[cis-5-norbornene-endo-3-carboxy-2-carboxamido]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[ethyl(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[methyl(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
5-[[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino]-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
5-[[(4-bromophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
5-[[(4-nitrophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
5-[[(pentafluorophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[[(phenylcarbamoyl)carbamothioyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{(2,4-dichlorobenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{(4-bromobenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{(4-chlorobenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{(4-fluorobenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{(4-methoxybenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{(4-methylbenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{(benzylsulfonyl)[2-(4-bromophenyl)ethyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{benzyl[(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{butyl[(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{dodecyl[(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{ethyl[(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{methyl[(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
5-{[(4-aminophenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
5-{[(4-methylphenyl)sulfonyl](2-methylpropyl)amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{[(4-methylphenyl)sulfonyl](2-phenylethyl)amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{[(4-methylphenyl)sulfonyl](3,4,5-trimethoxybenzyl)amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{[(4-methylphenyl)sulfonyl](pentyl)amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{[(4-methylphenyl)sulfonyl](propan-2-yl)amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{[(4-methylphenyl)sulfonyl](propyl)amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{[2-(4-bromophenyl)ethyl][(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{[3-(2-methoxyphenyl)propyl][(4-methylphenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
-
6,6,6-trichloro-11-oxo-8,9,10,10a,11,12-hexahydro-6H-6lambda5-pyrimido[1,2-c]pyrrolo[2,1-g][1,3,5,2]triazastibepin-5-ium
6,7-dimethoxy-1-ethyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide
-
6,7-dimethoxy-1-isopropyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide
-
6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide
-
6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide
-
6,7-dimethoxy-1-propyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide
-
6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one
-
6-(1-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one
-
-
6-(aminomethyl)-2H-chromen-2-one
-
6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid
-
6-(hydroxymethyl)-2H-chromen-2-one
-
6-acetyl-7-(benzyloxy)-2H-chromen-2-one
-
-
6-acetyl-7-adamantylethoxy-2H-chromen-2-one
-
-
6-acetyl-7-butoxy-2H-chromen-2-one
-
-
6-acetyl-7-ethoxy-2H-chromen-2-one
-
-
6-acetyl-7-hydroxy-2H-chromen-2-one
-
-
6-acetyl-7-methoxy-2H-chromen-2-one
-
-
6-acetyl-7-propoxy-2H-chromen-2-one
-
-
6-amino-1,3-dimethyluracil
inhibition of isozyme hCA I; inhibition of isozyme hCA II
6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide
6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~,2,4-benzothiadiazine-7-sulfonamide
-
-
6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-chloro-4-amino-benzene-1,3-disulfonamide
6-chloro-6,6-dimethyl-12-oxo-6,8,9,10,11,11a,12,13-octahydro-6lambda5-pyrido[2,1-g]pyrimido[1,2-c][1,3,5,2]triazastibepin-5-ium
6-deoxy-N-(4-sulfamoylphenyl)-alpha-L-mannopyranosylamine
-
6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine
-
-
6-ethoxy-1,3-benzothiazole-2-sulfonamide
6-ethoxy-2-benzo-thiazolesulfonamide
-
-
6-hydroxy-1,3-benzothiazole-2-sulfonamide
6-methoxy-2-oxo-2H-chromene-3-carboxylic acid
-
6-methyl-2-oxo-2H-chromene-3-carboxylic acid
-
6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
6-methylpyrimidine-2,4(1H,3H)-dione
inhibition of isozyme hCA I
6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide
7-(2-phenylethoxy)-2H-chromen-2-one
-
7-(benzyloxy)-2H-chromen-2-one
-
7-alpha-hydroxydehydroepiandrosterone sulfamate
-
-
7-butoxy-2H-chromen-2-one
-
7-ethoxy-2H-chromen-2-one
-
7-ethoxy-8-propanoyl-2H-chromen-2-one
-
-
7-hydroxy-1-methoxy-3-methyl-9-oxo-9,9a-dihydro-4aH-xanthene-8-carboxylic acid
-
-
7-hydroxy-3-(hydroxymethyl)-1-methoxy-9-oxo-9,9a-dihydro-4aH-xanthene-8-carboxylic acid
-
-
7-hydroxy-6-propanoyl-2H-chromen-2-one
-
-
7-hydroxy-8-propanoyl-2H-chromen-2-one
-
-
7-methoxy-2-oxo-2H-chromene-4-carboxylic acid
-
7-methoxy-2H-chromen-2-one
-
7-methoxy-8-propanoyl-2H-chromen-2-one
-
-
7-oxodehydroepiandrosterone sulfamate
-
-
7-propoxy-2H-chromen-2-one
-
7alpha-hydroxyepiandrosterone sulfamate
-
-
8-acetyl-7-(benzyloxy)-2H-chromen-2-one
-
-
8-acetyl-7-butoxy-2H-chromen-2-one
-
-
8-acetyl-7-ethoxy-2H-chromen-2-one
-
-
8-acetyl-7-hydroxy-2H-chromen-2-one
-
-
8-acetyl-7-methoxy-2H-chromen-2-one
-
-
8-acetyl-7-propoxy-2H-chromen-2-one
-
-
8-methoxy-2-oxo-2H-chromene-3-carboxylic acid
-
8-propanoyl-7-propoxy-2H-chromen-2-one
-
-
acetaldehyde
-
modification of carbonic anhydrase II with acetaldehyde leads to decreased enzyme activity, acetaldehyde (100 mM) in the presence of NaBH3(CN) causes 23.7% reduction in CA II activity, in the absence of NaBH3(CN) the activity is only slightly reduced
Acetylsalicylic acid
-
noncompetitive inhibition of isozymes carbonic anhydrase I and II
allylamine hydrochloride
-
-
allylsulfonamide hydrochloride
-
-
allylsulfonyl chloride
-
-
benzene-1,3-disulfonamide
Benzyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate
-
benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate
-
benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate
-
benzyl (2E)-3-(3-hydroperoxy-4-hydroxyphenyl)prop-2-enoate
-
benzyl 2-thioxobenzo[d]oxazol-3(2H)-carboxylate
-
-
benzylsulfonylsulfamic acid
bisulfate
weak, carbonic anhydrase XIII
catechin
-
a competitive inhibitor with 4-nitrophenylacetate as substrate
Cd2+
-
cadmium inhibits competitively
Chlorthalidone
chlorthalidone is a medium potency CA I, II, and IV inhibitor, a very effective inhibitor of CA VB, CA VII, CA IX, CA XII, and CA XIII and an ineffective inhibitor of isozymes CA III, VA, VI, and XIV
cholesteryl sulfamate
-
-
Co3+
-
competitive, strong inhibition of carbonic anhydrase esterase activity
COS
-
3 mM, slightly inhibitory
Cu-GGHSLN
time-dependent inactivation of carbonic anhydrase I activity, within 3 h carbonic anhydrase I activity is eliminated at 0.005 mM Cu-GGHSLN
-
cyclopentyl sulfamate
-
-
dehydroepiandrosterone sulfamate
dextran-bound acetazolamide
-
dibenzyl N',N'''-(tribromo-lambda5-stibanediyl)biscarbamimidothioate
36.0% inhibition of CO2 hydration reaction after 30 min
dibenzyl N',N'''-(trichloro-lambda5-stibanediyl)biscarbamimidothioate
diethyl dicarbonate
Halalkalibacterium halodurans
strong inhibition at 5 mM
diethyldithiocarbamate
-
-
diflunisal
-
noncompetitive inhibition of isozymes carbonic anhydrase I and II
dimethylsilyl para-toluenesulfonamidoborane
-
-
dimethylsilyl-diphenylaminoborane
-
-
dimethylsilyl-N-methyl-N-phenylaminoborane
-
-
dimethylsilylaminoborane
-
-
dimethylsilylboronic acid
-
-
dimethylsilylfluoroborane
-
-
dimethylsilylsulfonamidoborane
-
-
dinitrosalicylic acid
-
-
estradiol 17 beta-sulfamate
-
-
estradiol 3,17 beta-disulfamate
-
CA II inhibitor
ethoxazolamide
-
systemic carbonic anhydrase inhibitor
ethyl 2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylate 1,1-dioxide
-
-
ethyl 2-methyl-2H-thieno[3,2-e]-1,2-thiazine-3-carboxylate 1,1-dioxide
-
-
ethyl 3,4-dihydro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-3-carboxylate 1,1-dioxide
-
-
ethyl 3-(3-dimethylaminopropyl)-carbodiimide
Halalkalibacterium halodurans
80% inhibition at 5 mM, via irreversible modification of carboxyl groups or thepresence of catalytically active tyrosine in the enzyme molecule
ethyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate
-
ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate
-
fluorenylmethyl sulfamate
-
-
guanidine hydrochloride
-
-
heptane-1,7-diyl disulfamate
-
hydrogencarbonate
good inhibitor of the Co(II)-substituted enzyme
indapamide
indapamide is a quite ineffective inhibitor of isozymes CA I, II, III, VA, VI, and XIV, a medium potency CA IV and CA VB inhibitor, and a very effective inhibitor of isozymes CA VII, IX, XII, and XIII
iodoacetic acid
Halalkalibacterium halodurans
-
Isoorotic acid
inhibition of isozyme hCA I; inhibition of isozyme hCA II
isopropylsulfonylsulfamic acid
K3[Fe(CN)6]
-
isoenzyme I
K4[Fe(CN)6]
-
isoenzyme I
methyl (3-chloro-4-hydroxyphenyl)acetate
-
-
methyl 2-sulfanylbenzo[d]oxazole-5-carboxylate
-
27% inhibition
methyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate
-
methyl N-[(2,3,4,6-Tetra-O-acetyl-beta-D-glucosyl)sulfonyl]-L-4'-sulfamoylprolinate
-
methyl N-[(2,3,4,6-tetra-O-acetyl-beta-D-glucosyl)sulfonyl]-L-sulfamoylserinate
-
methyl-3-(3-phenylpropanoyl)-2,3-dihydro-2-thioxobenzo[d]oxazole-5-carboxylate
-
-
methylsulfonylsulfamic acid
Mn2+
-
73% residual activity at 1 mM
N'',N'''-bis[(E)-(2,3,4-trihydroxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2,3-dihydroxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2,4,6-trihydroxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-Bis[(E)-(2,4-dichlorophenyl)methylidene]carbonic dihydrazide
N'',N'''-bis[(E)-(2,5-dihydroxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2,6-dichlorophenyl)methylidene]carbonic dihydrazide
N'',N'''-bis[(E)-(2-bromophenyl)methylidene]carbonic dihydrazide
N'',N'''-bis[(E)-(2-chloro-5-nitrophenyl)methylidene]carbonic dihydrazide
N'',N'''-bis[(E)-(2-chlorophenyl)methylidene]carbonic dihydrazide
N'',N'''-bis[(E)-(2-fluorophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2-hydroxy-3-methoxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2-hydroxy-5-methoxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2-hydroxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2-methoxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2-nitrophenyl)methylidene]carbonic dihydrazide
N'',N'''-bis[(E)-(3,4-dimethoxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(3-ethoxy-2-hydroxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(3-hydroxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(3-methoxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(4-bromophenyl)methylidene]carbonic dihydrazide
N'',N'''-bis[(E)-(4-chlorophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(4-fluorophenyl)methylidene]carbonic dihydrazide
N'',N'''-bis[(E)-(4-hydroxyphenyl)methylidene]carbonic dihydrazide
-
-
N'',N'''-bis[(E)-(4-methoxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(4-nitrophenyl)methylidene]carbonic dihydrazide
N'',N'''-bis[(E)-(5-bromo-2-hydroxyphenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-phenylmethylidene]carbonic dihydrazide
-
N,N'-biphosphoryl-4,5-dichloro-1,3-benzenesulfonamide
-
-
N,N'-bis(benzylsulfonyl)allylamine
-
-
N,N'-bis(styrenesulfonyl)allylamine
-
-
N,N-dimethylamidimidodisulfuric acid
N,N-dimethylimidodisulfuric diamide
N-(1,1-dimethylethyl)-2-(3-methoxyphenyl)-3-[(2-propylaminol)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
N-(1,1-dimethylethyl)-2-(3-methoxyphenyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
-
-
N-(1,1-dimethylethyl)-2-[4-(4-morpholinyl)-2-butenyl]-2H-thieno[3,2-e-]-1,2-thiazine-6-sulfonamide 1,1-dioxide
-
-
N-(1-(2-hydroxyphenylamino)-3-methyl-1-oxobutan-2-ylcarbamothioyl)benzamide
i.e. NK-154, binding structure, overview; i.e. NK-154, binding structure, overview; i.e. NK-154, binding structure, overview
N-(1-(2-hydroxyphenylamino)-4-methyl-1-oxopentan-2-ylcarbamothioyl) benzamide
i.e. NK-168, binding structure, overview; i.e. NK-168, binding structure, overview; i.e. NK-168, binding structure, overview
N-(2-fluoro-4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide
-
-
N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
N-(4-bromophenyl)sulfuric diamide
-
-
N-(4-sulfamoylbenzyl)benzenesulfonamide
-
-
N-(4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide
-
-
N-(4-sulfamoylphenyl)-beta-D-galactopyranosylamine
-
N-(4-sulfamoylphenyl)-beta-D-idopyranosylamine
-
N-(4-sulfamoylphenyl)acetamide
-
-
N-(4-sulfamoylphenyl)benzamide
-
-
N-(4-sulfamoylphenyl)butanamide
-
-
N-(4-sulfamoylphenyl)pentanamide
-
-
N-(4-sulfamoylphenyl)propanamide
-
-
N-(4-[(4-sulfamoylphenyl)sulfamoyl]phenyl)acetamide
-
-
N-(4-[(E)-[(aminosulfonyl)imino]methyl]phenyl)acetamide
N-(4-[[(aminosulfonyl)amino]sulfonyl]phenyl)acetamide
N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)acetamide
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)furan-2-carboxamide
N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
N-(allylsulfonyl)allylamine
-
-
N-(allysulfonyl)-3-triethylsilylpropanamine
-
-
N-(aminosulfonyl)-1,1,1-trichloromethanesulfonamide
N-(aminosulfonyl)-1,1,1-trifluoromethanesulfonamide
N-(aminosulfonyl)-1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonamide
N-(aminosulfonyl)-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide
N-(aminosulfonyl)-1-(7,7-dimethylbicyclo[2.2.1]hept-1-yl)methanesulfonamide
N-(aminosulfonyl)-1-phenylmethanesulfonamide
N-(aminosulfonyl)-2,3,4,5,6-pentafluorobenzenesulfonamide
N-(aminosulfonyl)-2,4,6-triisopropylbenzenesulfonamide
N-(aminosulfonyl)-2,4,6-tripropylbenzenesulfonamide
N-(aminosulfonyl)-2,5-dichlorobenzenesulfonamide
N-(aminosulfonyl)-2-nitrobenzenesulfonamide
N-(aminosulfonyl)-3,5-dichloro-2-hydroxybenzenesulfonamide
N-(aminosulfonyl)-3-(trifluoromethyl)benzenesulfonamide
N-(aminosulfonyl)-3-chloro-4-nitrobenzenesulfonamide
N-(aminosulfonyl)-3-nitrobenzenesulfonamide
N-(aminosulfonyl)-4-bromobenzenesulfonamide
N-(aminosulfonyl)-4-chlorobenzenesulfonamide
N-(aminosulfonyl)-4-fluorobenzenesulfonamide
N-(aminosulfonyl)-4-iodobenzenesulfonamide
N-(aminosulfonyl)-4-methoxybenzenesulfonamide
N-(aminosulfonyl)-4-methylbenzenesulfonamide
N-(aminosulfonyl)-4-nitrobenzenesulfonamide
N-(aminosulfonyl)-5-(dimethylamino)naphthalene-1-sulfonamide
N-(aminosulfonyl)benzenesulfonamide
N-(aminosulfonyl)methanesulfonamide
N-(aminosulfonyl)naphthalene-1-sulfonamide
N-(aminosulfonyl)naphthalene-2-sulfonamide
N-(aminosulfonyl)propane-2-sulfonamide
N-(aminosulfonyl)quinoline-8-sulfonamide
N-(aminosulfonyl)thiophene-2-sulfonamide
N-(benzylsulfonyl)-3-tributylgermylpropanamine
-
-
N-(benzylsulfonyl)-3-triethylsilylpropanamine
-
-
N-(benzylsulfonyl)allylamine
-
-
N-(cyclopropylmethyl)-3-(1,3-dioxolan-2-yl)thiophene-2-sulfonamide
-
-
N-(dimesilylboro)allylsulfonamide
-
-
N-(styrenesulfonyl)-3-triethylsilylpropanamine
-
-
N-(trans-styrenesulfonyl)allylamine
-
-
N-2'-sulfamoylethyl-S-(2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosyl)sulfonamide
-
N-3'-R-sulfamoylpyrrolidinyl-S-(1-thio-beta-D-glucopyranosyl)sulfonamide
-
N-3'-R-sulfamoylpyrrolidinyl-S-(2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosyl)sulfonamide
-
N-3'-sulfamoylpropyl-S-(1-thio-beta-D-glucopyranosyl)sulfonamide
-
N-3'-sulfamoylpropyl-S-(2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosyl)sulfonamide
-
N-4'-sulfamoylpiperidinyl-S-(1-thio-beta-D-glucopyranosyl)sulfonamide
-
N-4'-sulfamoylpiperidinyl-S-(2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosyl)sulfonamide
-
N-4-methoxyphenylsulfonyl-N-2-nitrobenzyl-L-alanine hydroxamate
N-4-methoxyphenylsulfonyl-N-benzyl-L-valine hydroxamate
N-5'-sulfamoylpentyl-S-(1-thio-beta-D-glucopyranosyl)sulfonamide
-
N-5'-sulfamoylpentyl-S-(2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosyl)sulfonamide
-
N-allyl-1-phenylmethanesulfonamide
-
-
N-allylsulfonyl-3-[9-borabicyclo[1.3.3.]nonane]propanamine
-
-
N-benzyl-2-(3-chloro-4-hydroxyphenyl)acetamide
-
-
N-bromosuccinimide
Halalkalibacterium halodurans
strong inhibition at 5 mM
N-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide
-
-
N-cyclohexyl-N-[(3-formyl-thien-2-yl)sulfonyl]-glycine methyl ester
-
-
N-cyclopropylmethyl-3-(1,3-dioxolan-2-yl)-2-thiophenesulfonamide
-
-
n-decyl sulfamate
-
CA II inhibitor
N-ethylmaleimide
Halalkalibacterium halodurans
strong inhibition at 5 mM
n-hexadecyl sulfamate
-
-
N-hydroxysulfamide
isoenzyme hCA I; isoenzyme hCA IX; isoenzyme hCA XII; the inhibitor coordinates to the active site zinc ion by the ionized primary amino group, participating in an extended network of hydrogen bonds with amino acid residues Thr199, Thr200 and two water molecules, isoenzyme hCA II
N-n-perfluorobutylsulfonyl-alanine hydroxamate
n-octadecyl sulfamate
-
-
N-pentafluorophenylsulfonyl-glycine
N-pentafluorophenylsulfonyl-glycine hydroxamate
N-pentafluorophenylsulfonyl-N-4-nitrobenzyl-glycine hydroxamate
N-phenylsulfuric diamide
-
-
N-phosphoryl-4-carboxy-benzenesulfonamide
-
-
N-phosphoryl-6-nitro-benzothiazole-2-sulfonamide
-
-
N-phosphoryl-benzothiazole -2-sulfonamide
-
-
N-salicylidene-sulfanilic acid amide
N-salicylidene-sulfanilic acid amide cobalt acetate complex
N-salicylidene-sulfanilic acid amide cobalt chloride complex
N-salicylidene-sulfanilic acid amide cobalt nitrate complex
N-salicylidene-sulfanilic acid amide cobalt sulfate complex
N-salicylidene-sulfanilic acid amide copper chloride complex
N-salicylidene-sulfanilic acid amide copper nitrate complex
N-salicylidene-sulfanilic acid amide nickel acetate complex
N-salicylidene-sulfanilic acid amide nickel chloride complex
N-salicylidene-sulfanilic acid amide nickel nitrate complex
N-salicylidene-sulfanilic acid amide nickel sulfate complex
N-sulfamoyl-beta-D-galactopyranosylamine
-
-
N-sulfamoyl-beta-D-glucopyranosylamine
-
-
N-sulfamoyl-beta-D-mannopyranosylamine
-
-
N-tert-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide
-
-
n-tetradecyl sulfamate
-
most potent CA I inhibitor
N-trimethylsilylallylsulfonamide
-
-
N-[(1E)-(1-methyl-1H-pyrrol-2-yl)methylene]sulfamide
N-[(1E)-(3,4,5-trimethoxyphenyl)methylene]sulfamide
N-[(1E)-(3-nitrophenyl)methylene]sulfamide
N-[(1E)-(4-methoxyphenyl)methylene]sulfamide
N-[(1E)-(4-methylphenyl)methylene]sulfamide
N-[(1E)-(4-nitrophenyl)methylene]sulfamide
N-[(1E)-(5-methylthien-2-yl)methylene]sulfamide
N-[(1E)-phenylmethylene]sulfamide
N-[(1E)-thien-2-ylmethylene]sulfamide
N-[(1E)-[4-(dimethylamino)phenyl]methylene]sulfamide
N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
N-[(2E)-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]furan-2-carboxamide
-
-
N-[(3-formyl-2-thienyl)sulfonyl]-glycine ethyl ester
-
-
N-[(3-formyl-thien-2-yl)sulfonyl]-N-(2-methoxyethyl)-glycine ethyl ester
-
-
N-[(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]sulfamic amide
-
-
N-[(4-[[(4-sulfamoylphenyl)carbamothioyl]amino]phenyl)sulfonyl]acetamide
-
-
N-[2,4-disulfamoyl-5-(trifluoromethyl)phenyl]-2-(7-methoxy-2-oxo-2H-chromen-4-yl)acetamide
-
-
N-[2,4-disulfamoyl-5-(trifluoromethyl)phenyl]-2-oxo-2H-chromene-3-carboxamide
-
-
N-[4-(aminosulfonyl)phenyl]-2,2,2-trifluoroacetamide
N-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide
N-[4-(aminosulfonyl)phenyl]-2-methylpropanamide
N-[4-(aminosulfonyl)phenyl]acetamide
N-[4-(aminosulfonyl)phenyl]benzamide
N-[4-(aminosulfonyl)phenyl]butanamide
N-[4-(aminosulfonyl)phenyl]pentanamide
N-[4-(aminosulfonyl)phenyl]propanamide
N-[4-[(aminooxy)sulfinyl]phenyl]-4-[(diphenylcarbamoyl)amino]benzenesulfonamide
-
-
N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
N-[5-[(aminooxy)sulfinyl]-1,3,4-thiadiazol-2-yl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide
-
-
N-[[2-(1,3-dioxalan-2-yl)-3-thienyl]sulfonyl]-N-methylglycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)-2-thienyl]sulfonyl]-glycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-(1-methylethyl)-glycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-(2-propenyl)-glycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-(3-methoxyethyl)-glycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-ethylglycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-methylcyclopropyl-glycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-methylglycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-propylglycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-[(3,4-dimethoxyphenyl)methyl]-glycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-[(3-methoxyphenyl)methyl]-glycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-[(4-methoxyphenyl)methyl]-glycine ethyl ester
-
-
N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-[4-(morpholin-4-yl)phenyl]-glycine methyl ester
-
-
N-[[5-(aminosulfonyl)-2-formyl-thiophen-3-yl]sulfonyl]-N-methyl-glycine ethyl ester
-
-
N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-alanine
-
-
N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-asparagine
-
-
N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-glutamine
-
-
N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-isoleucine
-
-
N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-leucine
-
-
N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-methionine
-
-
N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-phenylalanine
-
-
N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-proline
-
-
N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-tryptophan
-
-
N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-valine
-
-
naphthalene-2-sulfonamide
-
-
N~1~-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
-
Orotic acid
inhibition of isozyme hCA I; inhibition of isozyme hCA II
orthanilamide
carbonic anhydrase XIII
p-(aminomethyl)-benzene-sulfonamide
a CAII inhibitor
p-(aminomethyl)-benzenesulfonamide
p-AMBS
p-aminomethylbenzenesulfonamide
p-biphenylmethyl sulfamate
-
-
p-hydroxymercuribenzoate
-
-
p-methylbenzyl sulfamate
-
-
pentachlorophenyl sulfamate
-
-
pentafluorophenyl sulfamate
-
-
perfluorobutanesulfonamide
phenyl methyl sulfonyl fluoride
-
-
phenylsulfamate
-
best CA I inhibitor
phenylsulfonylsulfamic acid
phosphate
binding structure analysis, overview. Phosphate binds to the catalytic zinc cofactor, each unit cell is comprised of four dimers of CrCAH3
PMSF
Halalkalibacterium halodurans
80% inhibition at 5 mM
prop-2-ene-1-sulfonamide
-
-
pyridoxal 5'-phosphate
-
-
quinolin-8-ylsulfonylsulfamic acid
silymarin
-
a competitive inhibitor with 4-nitrophenylacetate as substrate
sodium (butylsulfonyl)azanide
-
-
sodium (hexylsulfonyl)azanide
-
-
sodium (octylsulfonyl)azanide
-
-
sulfasalazine
-
noncompetitive inhibition of isozymes carbonic anhydrase I and II
Sulfonamides
-
affinity of carbonic anhydrase IV for sulfonamides is decreased up to 65fold compared to carbonic anhydrase II
tert-butyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate
-
tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate
-
tert-butyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate
-
tert-butyl 3-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate
tert-butyl 4-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate
tert-butyl 5-[[(aminosulfonyl)amino]sulfonyl]-2-hydroperoxyphenylcarbamate
thien-2-ylsulfonylsulfamic acid
trifluoromethanesulfonamide
U-shaped pH-dependence of the Gibbs energy of binding, the affinity is greatest in the near neutral pH region and diminished towards both the acidic and alkaline regions
tris(hydroxymethyl)phosphine
-
-
Triton X-100
Halalkalibacterium halodurans
-
Tween 80
Halalkalibacterium halodurans
-
Woodward's reagent K
Halalkalibacterium halodurans
WRK
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-2H,3aH,7H-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
-
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
[(7,7-dimethylbicyclo[2.2.1]hept-1-yl)methyl]sulfonylsulfamic acid
[3-(trifluoromethyl)phenyl]sulfonylsulfamic acid
[3-[(tert-butoxycarbonyl)amino]-4-hydroperoxyphenyl]sulfonylsulfamic acid
[3-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic acid
[4-(acetylamino)phenyl]sulfonylsulfamic acid
[4-[(aminooxy)sulfinyl]phenyl]methanol
-
-
[4-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic acid
[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]hydrazine
[5-(dimethylamino)-1-naphthyl]sulfonylsulfamic acid
[Co(1-benzyl-2-methylimidazole)2Cl2]
-
[Hg(1-benzyl-2-methylimidazole)2Cl2]
-
[Zn(1-benzyl-2-methylimidazole)2Cl2]
-
[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic acid
[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic amide
[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic acid
[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic amide
[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic acid
[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic amide
[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic acid
[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic amide
(2,4,6-triisopropylphenyl)sulfonylsulfamic acid
-
-
(2,4,6-triisopropylphenyl)sulfonylsulfamic acid
-
-
(2,4,6-tripropylphenyl)sulfonylsulfamic acid
-
-
(2,4,6-tripropylphenyl)sulfonylsulfamic acid
-
-
(2,5-dichlorophenyl)sulfonylsulfamic acid
-
-
(2,5-dichlorophenyl)sulfonylsulfamic acid
-
-
(2-nitrophenyl)sulfonylsulfamic acid
-
-
(2-nitrophenyl)sulfonylsulfamic acid
-
-
(2Z)-2-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(3-bromobenzylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(3-bromobenzylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(3-methoxybenzylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(3-methoxybenzylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(4-chlorobenzylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(4-chlorobenzylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(4-methylpentan-2-ylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(4-methylpentan-2-ylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-benzylidene-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(2Z)-2-benzylidene-N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
(3,5-dichloro-2-hydroxyphenyl)sulfonylsulfamic acid
-
-
(3,5-dichloro-2-hydroxyphenyl)sulfonylsulfamic acid
-
-
(3-chloro-4-nitrophenyl)sulfonylsulfamic acid
-
-
(3-chloro-4-nitrophenyl)sulfonylsulfamic acid
-
-
(3-nitrophenyl)sulfonylsulfamic acid
-
-
(3-nitrophenyl)sulfonylsulfamic acid
-
-
(4-acetylphenyl)sulfonylsulfamic acid
-
-
(4-acetylphenyl)sulfonylsulfamic acid
-
-
(4-bromophenyl)sulfonylsulfamic acid
-
-
(4-bromophenyl)sulfonylsulfamic acid
-
-
(4-chlorophenyl)sulfonylsulfamic acid
-
-
(4-chlorophenyl)sulfonylsulfamic acid
-
-
(4-fluorophenyl)sulfonylsulfamic acid
-
-
(4-fluorophenyl)sulfonylsulfamic acid
-
-
(4-iodophenyl)sulfonylsulfamic acid
-
-
(4-iodophenyl)sulfonylsulfamic acid
-
-
(4-methoxyphenyl)sulfonylsulfamic acid
-
-
(4-methoxyphenyl)sulfonylsulfamic acid
-
-
(4-methylphenyl)sulfonylsulfamic acid
-
-
(4-methylphenyl)sulfonylsulfamic acid
-
-
(4-nitrophenyl)sulfonylsulfamic acid
-
-
(4-nitrophenyl)sulfonylsulfamic acid
-
-
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
-
-
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
-
-
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
-
-
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
-
-
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
-
-
(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
-
-
(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
-
-
(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
-
-
(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
-
-
(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
-
-
(heptadecafluorooctyl)sulfonylsulfamic acid
-
-
(heptadecafluorooctyl)sulfonylsulfamic acid
-
-
(nonafluorobutyl)sulfonylsulfamic acid
-
-
(nonafluorobutyl)sulfonylsulfamic acid
-
-
(pentafluorophenyl)sulfonylsulfamic acid
-
-
(pentafluorophenyl)sulfonylsulfamic acid
-
-
(trichloromethyl)sulfonylsulfamic acid
-
-
(trichloromethyl)sulfonylsulfamic acid
-
-
(trifluoromethyl)sulfonylsulfamic acid
-
-
(trifluoromethyl)sulfonylsulfamic acid
-
-
1,1'-(tribromo-lambda5-stibanediyl)bis(2-aminopyridin-1-ium)
29.9% inhibition of CO2 hydration reaction after 30 min
1,1'-(tribromo-lambda5-stibanediyl)bis(2-aminopyridin-1-ium)
31.6% inhibition of CO2 hydration reaction after 30 min
1,1'-(tribromo-lambda5-stibanediyl)bis(2-aminopyrimidin-1-ium)
57.6% inhibition of CO2 hydration reaction after 30 min
1,1'-(tribromo-lambda5-stibanediyl)bis(2-aminopyrimidin-1-ium)
16.3% inhibition of CO2 hydration reaction after 30 min
1,1'-(trichloro-lambda5-stibanediyl)bis(2-amino-4,6-dimethoxy-5-sulfanylpyrimidin-1-ium)
99.3% inhibition of CO2 hydration reaction after 30 min
1,1'-(trichloro-lambda5-stibanediyl)bis(2-amino-4,6-dimethoxy-5-sulfanylpyrimidin-1-ium)
64.8% inhibition of CO2 hydration reaction after 30 min
1,1'-(trichloro-lambda5-stibanediyl)bis(2-aminopyridin-1-ium)
49.2% inhibition of CO2 hydration reaction after 30 min
1,1'-(trichloro-lambda5-stibanediyl)bis(2-aminopyridin-1-ium)
9.4% inhibition of CO2 hydration reaction after 30 min
1,1'-(trichloro-lambda5-stibanediyl)bis(2-aminopyrimidin-1-ium)
98.4% inhibition of CO2 hydration reaction after 30 min
1,1'-(trichloro-lambda5-stibanediyl)bis(2-aminopyrimidin-1-ium)
90.2% inhibition of CO2 hydration reaction after 30 min
1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-n-hexane-1-sulfonamide
-
-
1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-n-hexane-1-sulfonamide
-
-
1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-n-heptane-1-sulfonamide
-
-
1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-n-heptane-1-sulfonamide
-
-
1,2-benzothiazol-3(2H)-one 1,1-dioxide
-
-
1,2-benzothiazol-3(2H)-one 1,1-dioxide
-
-
1,2-benzothiazol-3(2H)-one 1,1-dioxide
-
-
1,2-benzothiazol-3(2H)-one 1,1-dioxide
-
-
1,2-benzothiazol-3(2H)-one 1,1-dioxide
-
-
1,5-bis[amino(dihydroxy)-lambda4-sulfanyl]-2,3-dichlorobenzene
-
1,5-bis[amino(dihydroxy)-lambda4-sulfanyl]-2,3-dichlorobenzene
-
-
1-(1,2-benzoxazol-3-yl)methanesulfonamide
-
-
1-(1,2-benzoxazol-3-yl)methanesulfonamide
-
-
1-(1,2-benzoxazol-3-yl)methanesulfonamide
-
-
1-(1,2-benzoxazol-3-yl)methanesulfonamide
-
-
1-(1,2-benzoxazol-3-yl)methanesulfonamide
-
1-(1,2-benzoxazol-3-yl)methanesulfonamide
-
-
1-(1,2-benzoxazol-3-yl)methanesulfonamide
-
-
1-(1,2-benzoxazol-3-yl)methanesulfonamide
-
-
1-naphthylsulfonylsulfamic acid
-
-
1-naphthylsulfonylsulfamic acid
-
-
1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]ethanamine
-
1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]ethanamine
-
-
1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]methanamine
-
1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]methanamine
-
-
12,12,12-tribromo-7-oxo-6,7a,8,9,10,12-hexahydro-7H-12lambda5-pyrrolo[1',2':1,7][1,3,5,2]triazastibepino[4,3-b][1,3]benzothiazol-13-ium
92.3% inhibition of CO2 hydration reaction after 30 min
12,12,12-tribromo-7-oxo-6,7a,8,9,10,12-hexahydro-7H-12lambda5-pyrrolo[1',2':1,7][1,3,5,2]triazastibepino[4,3-b][1,3]benzothiazol-13-ium
11.1% inhibition of CO2 hydration reaction after 30 min; 18.4% inhibition of CO2 hydration reaction after 30 min
2,4-bis[amino(dihydroxy)-lamba4-sulfanyl]-5-(trifluoromethyl)aniline
-
2,4-bis[amino(dihydroxy)-lamba4-sulfanyl]-5-(trifluoromethyl)aniline
-
-
2,4-bis[amino(dihydroxy)-lambda4-sulfanyl]-5-chloroaniline
-
2,4-bis[amino(dihydroxy)-lambda4-sulfanyl]-5-chloroaniline
-
-
2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
isoenzyme hpalphaCA; isoenzyme hpbetaCA
2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA XII; isoenzyme hCA XIV
2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
isoenzyme gammaCA
2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide
O14939, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV catalytic domain
2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide
efficient inhibitor of only isozymes CA I and II
2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide
isoenzyme mCA XIII
2-(hydroxymethyl)-4-nitro-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
-
2-(hydroxymethyl)-4-nitro-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
-
2-aminobenzenesulfonamide
-
-
2-aminobenzenesulfonamide
-
2-aminobenzenesulfonamide
-
-
2-aminobenzenesulfonamide
-
2-aminobenzenesulfonamide
-
2-aminobenzenesulfonamide
-
-
2-aminobenzenesulfonamide
-
2-aminobenzenesulfonamide
-
-
2-aminobenzenesulfonamide
-
-
2-aminobenzenesulfonamide
-
-
2-hydrazinobenzenesulfonamide
-
2-hydrazinobenzenesulfonamide
-
2-hydrazinobenzenesulfonamide
-
2-hydrazinylbenzenesulfonamide
-
-
2-hydrazinylbenzenesulfonamide
-
2-hydrazinylbenzenesulfonamide
-
-
2-hydrazinylbenzenesulfonamide
-
-
2-hydrazinylbenzenesulfonamide
-
-
2-mercaptoethanol
Halalkalibacterium halodurans
15% inhibition at 5 mM
2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide
-
-
2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide
-
-
2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide
-
-
2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide
-
2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide
-
-
2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide
-
-
2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV
2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide
isoenzyme mCA XIII
2-naphthylsulfonylsulfamic acid
-
-
2-naphthylsulfonylsulfamic acid
-
-
2-[[(5-chlorothiophen-2-yl)(hydroxy)methyl]amino]-1-(trichloro[2-[2-(5-chlorothiophen-2-yl)-2-oxoethyl]pyrimidin-1-ium-1-yl]-lambda5-stibanyl)pyrimidin-1-ium
18.7% inhibition of CO2 hydration reaction after 30 min
2-[[(5-chlorothiophen-2-yl)(hydroxy)methyl]amino]-1-(trichloro[2-[2-(5-chlorothiophen-2-yl)-2-oxoethyl]pyrimidin-1-ium-1-yl]-lambda5-stibanyl)pyrimidin-1-ium
62.5% inhibition of CO2 hydration reaction after 30 min
3,3,4,4,5,5,6,6,6-nonafluoro-n-hexanesulfonamide
-
-
3,3,4,4,5,5,6,6,6-nonafluoro-n-hexanesulfonamide
-
-
3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-n-octanesulfonamide
-
-
3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-n-octanesulfonamide
-
-
3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-n-decanesulfonamide
-
-
3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-n-decanesulfonamide
-
-
3,5-dichloro-2-hydroxybenzenesulfonamide
-
-
3,5-dichloro-2-hydroxybenzenesulfonamide
-
-
3-(4-sulfamoylphenyl)propanoic acid
-
-
3-(4-sulfamoylphenyl)propanoic acid
-
-
3-(4-sulfamoylphenyl)propanoic acid
-
-
3-aminobenzenesulfonamide
-
-
3-aminobenzenesulfonamide
-
-
3-[(anilinocarbonyl)amino]benzenesulfonamide
-
3-[(anilinocarbonyl)amino]benzenesulfonamide
-
-
3-[(sulfoamino)sulfonyl]benzoic acid
-
-
3-[(sulfoamino)sulfonyl]benzoic acid
-
-
3-[amino(dihydroxy)-lambda4-sulfanyl]aniline
-
3-[amino(dihydroxy)-lambda4-sulfanyl]aniline
-
-
3-[[(aminosulfonyl)amino]sulfonyl]benzoic acid
-
-
3-[[(aminosulfonyl)amino]sulfonyl]benzoic acid
-
-
4,5-dichloro-benzene-1,3-disulfonamide
-
4,5-dichloro-benzene-1,3-disulfonamide
isoenzyme hpalphaCA, i.e. daranide; isoenzyme hpbetaCA, i.e. daranide
4,5-dichloro-benzene-1,3-disulfonamide
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I, i.e. daranide; isoenzyme hCA II, i.e. daranide; isoenzyme hCA III, i.e. daranide; isoenzyme hCA IV, i.e. daranide; isoenzyme hCA IX, i.e. daranide; isoenzyme hCA VA, i.e. daranide; isoenzyme hCA VB, i.e. daranide; isoenzyme hCA VI, i.e. daranide; isoenzyme hCA VII, i.e. daranide; isoenzyme hCA XII, i.e. daranide; isoenzyme hCA XIV, i.e. daranide
4,5-dichloro-benzene-1,3-disulfonamide
isoenzyme gammaCA, i.e. daranide
4,5-dichloro-benzene-1,3-disulfonamide
isoenzyme mCA XIII, i.e. daranide
4,5-dichloro-benzene-1,3-disulfonamide
-
-
4,5-dichloro-benzene-1,3-disulfonamide
-
shows effective carbonic anhydrase inhibitory activity
4,5-dichlorobenzene-1,3-disulfonamide
-
-
4,5-dichlorobenzene-1,3-disulfonamide
-
-
4,5-dichlorobenzene-1,3-disulfonamide
-
-
4,5-dichlorobenzene-1,3-disulfonamide
-
-
4,5-dichlorobenzene-1,3-disulfonamide
-
4,5-dichlorobenzene-1,3-disulfonamide
-
-
4,5-dichlorobenzene-1,3-disulfonamide
-
-
4,5-dichlorobenzene-1,3-disulfonamide
-
-
4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide
-
-
4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide
-
-
4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide
-
-
4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide
-
-
4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide
-
-
4-(2-amino-pyrimidin-4-yl)-benzenesulfonamide
-
-
4-(2-amino-pyrimidin-4-yl)-benzenesulfonamide
-
best inhibitor
4-(2-amino-pyrimidin-4-yl)-benzenesulfonamide
-
-
4-(2-aminoethyl)benzenesulfonamide
-
-
4-(2-aminoethyl)benzenesulfonamide
-
4-(2-aminoethyl)benzenesulfonamide
-
-
4-(2-aminoethyl)benzenesulfonamide
-
4-(2-aminoethyl)benzenesulfonamide
-
4-(2-aminoethyl)benzenesulfonamide
-
-
4-(2-aminoethyl)benzenesulfonamide
-
-
4-(2-aminoethyl)benzenesulfonamide
-
-
4-(2-aminoethyl)benzenesulfonamide
-
4-(2-aminoethyl)benzenesulfonamide
-
-
4-(2-aminoethyl)benzenesulfonamide
-
-
4-(2-aminoethyl)benzenesulfonamide
-
-
4-(2-aminoethyl)benzenesulfonamide
-
-
4-(2-hydroxyethyl)benzenesulfonamide
-
-
4-(2-hydroxyethyl)benzenesulfonamide
-
4-(2-hydroxyethyl)benzenesulfonamide
-
-
4-(2-hydroxyethyl)benzenesulfonamide
-
4-(2-hydroxyethyl)benzenesulfonamide
-
4-(2-hydroxyethyl)benzenesulfonamide
-
-
4-(2-hydroxyethyl)benzenesulfonamide
-
-
4-(2-hydroxyethyl)benzenesulfonamide
-
-
4-(2-hydroxyethyl)benzenesulfonamide
-
4-(2-hydroxyethyl)benzenesulfonamide
-
-
4-(2-hydroxyethyl)benzenesulfonamide
-
-
4-(2-hydroxyethyl)benzenesulfonamide
-
-
4-(2-hydroxyethyl)benzenesulfonamide
-
-
4-(2-phenylacetamido)-3-bromobenzenesulfonamide
-
-
4-(2-phenylacetamido)-3-bromobenzenesulfonamide
-
4-(2-phenylacetamido)-3-chlorobenzenesulfonamide
-
-
4-(2-phenylacetamido)-3-chlorobenzenesulfonamide
-
4-(2-phenylacetamido)-3-fluorobenzenesulfonamide
-
-
4-(2-phenylacetamido)-3-fluorobenzenesulfonamide
-
4-(2-phenylacetamido)benzenesulfonamide
-
-
4-(2-phenylacetamido)benzenesulfonamide
-
4-(2-phenylacetamidoethyl)benzenesulfonamide
-
-
4-(2-phenylacetamidoethyl)benzenesulfonamide
-
4-(2-phenylacetamidomethyl)benzenesulfonamide
-
-
4-(2-phenylacetamidomethyl)benzenesulfonamide
-
4-(2-pyridin-2-ylacetamido)benzenesulfonamide
-
-
4-(2-pyridin-2-ylacetamido)benzenesulfonamide
-
4-(2-pyridin-4-ylacetamido)benzenesulfonamide
-
-
4-(2-pyridin-4-ylacetamido)benzenesulfonamide
-
4-(2-pyridin-4-ylacetamidoethyl)benzenesulfonamide
-
-
4-(2-pyridin-4-ylacetamidoethyl)benzenesulfonamide
-
4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
-
-
4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
-
-
4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
-
-
4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
-
-
4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
-
-
4-(aminomethyl)benzenesulfonamide
-
-
4-(aminomethyl)benzenesulfonamide
-
4-(aminomethyl)benzenesulfonamide
-
-
4-(aminomethyl)benzenesulfonamide
-
4-(aminomethyl)benzenesulfonamide
-
4-(aminomethyl)benzenesulfonamide
-
-
4-(aminomethyl)benzenesulfonamide
-
-
4-(aminomethyl)benzenesulfonamide
-
4-(aminomethyl)benzenesulfonamide
-
-
4-(aminomethyl)benzenesulfonamide
-
-
4-(aminomethyl)benzenesulfonamide
-
-
4-(aminomethyl)benzenesulfonamide
-
-
4-(aminosulfonyl)-N-[2-[4-(aminosulfonyl)phenyl]ethyl]benzamide
-
4-(aminosulfonyl)-N-[2-[4-(aminosulfonyl)phenyl]ethyl]benzamide
-
-
4-(aminosulfonyl)benzoic acid
-
4-(aminosulfonyl)benzoic acid
-
4-(hydroxymethyl)benzenesulfonamide
-
-
4-(hydroxymethyl)benzenesulfonamide
-
4-(hydroxymethyl)benzenesulfonamide
-
-
4-(hydroxymethyl)benzenesulfonamide
-
4-(hydroxymethyl)benzenesulfonamide
-
4-(hydroxymethyl)benzenesulfonamide
-
-
4-(hydroxymethyl)benzenesulfonamide
-
-
4-(hydroxymethyl)benzenesulfonamide
-
4-(hydroxymethyl)benzenesulfonamide
-
-
4-(hydroxymethyl)benzenesulfonamide
-
-
4-(hydroxymethyl)benzenesulfonamide
-
-
4-(hydroxymethyl)benzenesulfonamide
-
-
4-acetyl-N-(aminosulfonyl)benzenesulfonamide
-
-
4-acetyl-N-(aminosulfonyl)benzenesulfonamide
-
-
4-amino-3,5-dibromobenzenesulfonamide
-
-
4-amino-3,5-dibromobenzenesulfonamide
-
4-amino-3,5-dibromobenzenesulfonamide
-
-
4-amino-3,5-dibromobenzenesulfonamide
-
4-amino-3,5-dibromobenzenesulfonamide
-
-
4-amino-3,5-diiodobenzenesulfonamide
-
-
4-amino-3,5-diiodobenzenesulfonamide
-
4-amino-3,5-diiodobenzenesulfonamide
-
-
4-amino-3,5-diiodobenzenesulfonamide
-
-
4-amino-3-bromobenzenesulfonamide
-
4-amino-3-bromobenzenesulfonamide
-
-
4-amino-3-bromobenzenesulfonamide
-
-
4-amino-3-bromobenzenesulfonamide
-
4-amino-3-bromobenzenesulfonamide
-
-
4-amino-3-bromobenzenesulfonamide
-
-
4-amino-3-bromobenzenesulfonamide
-
-
4-amino-3-chlorobenzenesulfonamide
-
-
4-amino-3-chlorobenzenesulfonamide
-
4-amino-3-chlorobenzenesulfonamide
-
-
4-amino-3-chlorobenzenesulfonamide
-
4-amino-3-chlorobenzenesulfonamide
-
4-amino-3-chlorobenzenesulfonamide
-
-
4-amino-3-chlorobenzenesulfonamide
-
-
4-amino-3-chlorobenzenesulfonamide
-
4-amino-3-chlorobenzenesulfonamide
-
-
4-amino-3-chlorobenzenesulfonamide
-
-
4-amino-3-chlorobenzenesulfonamide
-
-
4-amino-3-chlorobenzenesulfonamide
-
-
4-amino-3-fluorobenzenesulfonamide
-
-
4-amino-3-fluorobenzenesulfonamide
-
4-amino-3-fluorobenzenesulfonamide
-
-
4-amino-3-fluorobenzenesulfonamide
-
4-amino-3-fluorobenzenesulfonamide
-
4-amino-3-fluorobenzenesulfonamide
-
-
4-amino-3-fluorobenzenesulfonamide
-
-
4-amino-3-fluorobenzenesulfonamide
-
-
4-amino-3-fluorobenzenesulfonamide
-
4-amino-3-fluorobenzenesulfonamide
-
-
4-amino-3-fluorobenzenesulfonamide
-
-
4-amino-3-fluorobenzenesulfonamide
-
-
4-amino-3-fluorobenzenesulfonamide
-
-
4-amino-3-iodobenzenesulfonamide
-
4-amino-3-iodobenzenesulfonamide
-
-
4-amino-3-iodobenzenesulfonamide
-
4-amino-3-iodobenzenesulfonamide
-
-
4-amino-3-iodobenzenesulfonamide
-
-
4-amino-3-iodobenzenesulfonamide
-
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
-
4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
-
4-amino-6-chlorobenzene-1,3-disulfonamide
-
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylphenyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylphenyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylphenyl)benzenesulfonamide
-
-
4-amino-N-(4-sulfamoylphenyl)benzenesulfonamide
-
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
-
4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide
-
-
4-amino-N-[4-(aminosulfonyl)benzyl]benzenesulfonamide
-
4-amino-N-[4-(aminosulfonyl)benzyl]benzenesulfonamide
-
4-amino-N-{2-[4-(aminosulfonyl)phenyl]ethyl}benzenesulfonamide
-
4-amino-N-{2-[4-(aminosulfonyl)phenyl]ethyl}benzenesulfonamide
-
4-Aminobenzenesulfonamide
-
-
4-Aminobenzenesulfonamide
-
-
4-Aminobenzenesulfonamide
-
4-Aminobenzenesulfonamide
-
-
4-Aminobenzenesulfonamide
-
-
4-Aminobenzenesulfonamide
-
-
4-Aminobenzenesulfonamide
-
4-Aminobenzenesulfonamide
-
4-Aminobenzenesulfonamide
-
-
4-Aminobenzenesulfonamide
-
-
4-Aminobenzenesulfonamide
-
-
4-Aminobenzenesulfonamide
-
4-Aminobenzenesulfonamide
-
-
4-Aminobenzenesulfonamide
-
-
4-Aminobenzenesulfonamide
-
-
4-Aminobenzenesulfonamide
-
-
4-aminoethyl-benzenesulfonamide
-
-
4-aminoethyl-benzenesulfonamide
carbonic anhydrase XIII
4-bromobenzenesulfonamide
-
-
4-bromobenzenesulfonamide
-
-
4-bromophenyl sulfamate
-
-
4-bromophenyl sulfamate
-
-
4-chlorophenyl sulfamate
-
4-chlorophenyl sulfamate
-
best CA IX inhibitor
4-hydrazinobenzenesulfonamide
-
4-hydrazinobenzenesulfonamide
-
4-hydrazinylbenzenesulfonamide
-
-
4-hydrazinylbenzenesulfonamide
-
4-hydrazinylbenzenesulfonamide
-
-
4-hydrazinylbenzenesulfonamide
-
-
4-hydrazinylbenzenesulfonamide
-
-
4-hydroxybenzenesulfonamide
-
-
4-hydroxybenzenesulfonamide
-
-
4-hydroxybenzenesulfonamide
-
-
4-iodobenzenesulfonamide
-
-
4-iodobenzenesulfonamide
-
-
4-methylbenzene-1-sulfonamide
-
4-methylbenzene-1-sulfonamide
-
-
4-methylbenzenesulfonamide
-
4-methylbenzenesulfonamide
-
-
4-methylbenzenesulfonamide
-
4-methylbenzenesulfonamide
-
4-methylbenzenesulfonamide
-
4-methylbenzenesulfonamide
-
-
4-methylbenzenesulfonamide
-
-
4-methylbenzenesulfonamide
-
-
4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide
-
-
4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide
-
4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide
-
-
4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide
-
-
4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide
-
-
4-sulfamoylbenzoic acid
-
-
4-sulfamoylbenzoic acid
-
4-sulfamoylbenzoic acid
-
-
4-sulfamoylbenzoic acid
-
-
4-sulfamoylbenzoic acid
-
-
4-sulfamoylbenzoic acid
-
4-sulfamoylbenzoic acid
-
-
4-sulfamoylbenzoic acid
-
4-sulfamoylbenzoic acid
-
-
4-sulfamoylbenzoic acid
-
-
4-sulfamoylbenzoic acid
-
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
-
4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide
-
-
4-[(acetyloxy)amino]-N-[4-(aminosulfonyl)phenyl]benzenesulfonamide
-
4-[(acetyloxy)amino]-N-[4-(aminosulfonyl)phenyl]benzenesulfonamide
-
-
4-[(anilinocarbonyl)amino]-6-chlorobenzene-1,3-disulfonamide
-
4-[(anilinocarbonyl)amino]-6-chlorobenzene-1,3-disulfonamide
-
-
4-[(methylsulfonyl)amino]benzenesulfonamide
-
-
4-[(methylsulfonyl)amino]benzenesulfonamide
-
4-[(methylsulfonyl)amino]benzenesulfonamide
-
-
4-[(phenylsulfonyl)amino]benzenesulfonamide
-
-
4-[(phenylsulfonyl)amino]benzenesulfonamide
-
4-[(phenylsulfonyl)amino]benzenesulfonamide
-
-
4-[(sulfoamino)sulfonyl]benzoic acid
-
-
4-[(sulfoamino)sulfonyl]benzoic acid
-
-
4-[2-(2-thienyl)acetamidoethyl]benzenesulfonamide
-
-
4-[2-(2-thienyl)acetamidoethyl]benzenesulfonamide
-
4-[2-(2-thienyl)acetamidomethyl]benzenesulfonamide
-
-
4-[2-(2-thienyl)acetamidomethyl]benzenesulfonamide
-
4-[2-(2-thienyl)acetamido]-3-bromobenzenesulfonamide
-
-
4-[2-(2-thienyl)acetamido]-3-bromobenzenesulfonamide
-
4-[2-(2-thienyl)acetamido]-3-chlorobenzenesulfonamide
-
-
4-[2-(2-thienyl)acetamido]-3-chlorobenzenesulfonamide
-
4-[2-(2-thienyl)acetamido]-3-fluorobenzenesulfonamide
-
-
4-[2-(2-thienyl)acetamido]-3-fluorobenzenesulfonamide
-
4-[2-(2-thienyl)acetamido]benzenesulfonamide
-
-
4-[2-(2-thienyl)acetamido]benzenesulfonamide
-
4-[2-[(anilinocarbonothioyl)amino]ethyl]benzenesulfonamide
-
4-[2-[(anilinocarbonothioyl)amino]ethyl]benzenesulfonamide
-
-
4-[2-[(anilinocarbonyl)amino]ethyl]benzenesulfonamide
-
4-[2-[(anilinocarbonyl)amino]ethyl]benzenesulfonamide
-
-
4-[2-[([[4-(aminosulfonyl)phenyl]amino]carbonothioyl)amino]ethyl]benzenesulfonamide
-
4-[2-[([[4-(aminosulfonyl)phenyl]amino]carbonothioyl)amino]ethyl]benzenesulfonamide
-
-
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
-
-
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
-
-
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
-
-
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
-
-
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
-
-
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
-
-
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-bromoaniline
-
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-bromoaniline
-
-
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-chloroaniline
-
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-chloroaniline
-
-
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-fluoroaniline
-
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-fluoroaniline
-
-
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-iodoaniline
-
4-[amino(dihydroxy)-lambda4-sulfanyl]-2-iodoaniline
-
-
4-[[(aminosulfonyl)amino]sulfonyl]benzoic acid
-
-
4-[[(aminosulfonyl)amino]sulfonyl]benzoic acid
-
-
4-[[(anilinocarbonothioyl)amino]methyl]benzenesulfonamide
-
4-[[(anilinocarbonothioyl)amino]methyl]benzenesulfonamide
-
-
4-[[(phenylsulfonyl)amino]methyl]benzenesulfonamide
-
4-[[(phenylsulfonyl)amino]methyl]benzenesulfonamide
-
-
5,5,5-tribromo-1,2,3,7,8,9,9a,11,16,17a-decahydro-5H-5lambda5-dipyrrolo[2,1-c:1',2'-f][1,4,6,9,5]benzotetraazastibacycloundecine-10,17-dione
83.9% inhibition of CO2 hydration reaction after 30 min
5,5,5-tribromo-1,2,3,7,8,9,9a,11,16,17a-decahydro-5H-5lambda5-dipyrrolo[2,1-c:1',2'-f][1,4,6,9,5]benzotetraazastibacycloundecine-10,17-dione
9.9% inhibition of CO2 hydration reaction after 30 min
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(2-phenylacetamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(2-phenylacetamido)-1,3,4-thiadiazole-2-sulfonamide
-
5-(3-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(3-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-([(4-aminophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-([(4-aminophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-([(4-aminophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-acetamido-1,3,4-thiadiazole-2-sulfonamide
-
-
5-acetamido-1,3,4-thiadiazole-2-sulfonamide
-
-
5-acetamido-1,3,4-thiadiazole-2-sulfonamide
-
5-acetamido-1,3,4-thiadiazole-2-sulfonamide
-
-
5-acetamido-1,3,4-thiadiazole-2-sulfonamide
-
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
-
5-amino-1,3,4-thiadiazole-2-sulfonamide
-
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
-
5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[2-(2-thienyl)acetamido]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[2-(2-thienyl)acetamido]-1,3,4-thiadiazole-2-sulfonamide
-
5-[[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino]-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
5-[[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino]-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[[(4-bromophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
5-[[(4-bromophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-[[(4-nitrophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
5-[[(4-nitrophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide
-
-
5-{[(4-aminophenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
5-{[(4-aminophenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
-
6,6,6-trichloro-11-oxo-8,9,10,10a,11,12-hexahydro-6H-6lambda5-pyrimido[1,2-c]pyrrolo[2,1-g][1,3,5,2]triazastibepin-5-ium
31.0% inhibition of CO2 hydration reaction after 30 min
6,6,6-trichloro-11-oxo-8,9,10,10a,11,12-hexahydro-6H-6lambda5-pyrimido[1,2-c]pyrrolo[2,1-g][1,3,5,2]triazastibepin-5-ium
25.1% inhibition of CO2 hydration reaction after 30 min
6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide
-
6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide
-
-
6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
-
-
6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
-
-
6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
-
-
6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
-
-
6-chloro-4-amino-benzene-1,3-disulfonamide
isoenzyme hpalphaCA; isoenzyme hpbetaCA
6-chloro-4-amino-benzene-1,3-disulfonamide
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV
6-chloro-4-amino-benzene-1,3-disulfonamide
isoenzyme gammaCA
6-chloro-4-amino-benzene-1,3-disulfonamide
isoenzyme mCA XIII
6-chloro-6,6-dimethyl-12-oxo-6,8,9,10,11,11a,12,13-octahydro-6lambda5-pyrido[2,1-g]pyrimido[1,2-c][1,3,5,2]triazastibepin-5-ium
99.3% inhibition of CO2 hydration reaction after 30 min
6-chloro-6,6-dimethyl-12-oxo-6,8,9,10,11,11a,12,13-octahydro-6lambda5-pyrido[2,1-g]pyrimido[1,2-c][1,3,5,2]triazastibepin-5-ium
22.9% inhibition of CO2 hydration reaction after 30 min
6-ethoxy-1,3-benzothiazole-2-sulfonamide
-
-
6-ethoxy-1,3-benzothiazole-2-sulfonamide
-
-
6-ethoxy-1,3-benzothiazole-2-sulfonamide
-
-
6-ethoxy-1,3-benzothiazole-2-sulfonamide
-
-
6-ethoxy-1,3-benzothiazole-2-sulfonamide
-
-
6-ethoxy-1,3-benzothiazole-2-sulfonamide
-
6-ethoxy-1,3-benzothiazole-2-sulfonamide
-
-
6-ethoxy-1,3-benzothiazole-2-sulfonamide
-
-
6-ethoxy-1,3-benzothiazole-2-sulfonamide
-
-
6-hydroxy-1,3-benzothiazole-2-sulfonamide
-
-
6-hydroxy-1,3-benzothiazole-2-sulfonamide
-
6-hydroxy-1,3-benzothiazole-2-sulfonamide
-
-
6-hydroxy-1,3-benzothiazole-2-sulfonamide
-
6-hydroxy-1,3-benzothiazole-2-sulfonamide
-
6-hydroxy-1,3-benzothiazole-2-sulfonamide
-
-
6-hydroxy-1,3-benzothiazole-2-sulfonamide
-
-
6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
isoenzyme hpalphaCA; isoenzyme hpbetaCA
6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA III; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA XII; isoenzyme hCA XIV
6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
isoenzyme gammaCA
6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
isoenzyme mCA XIII
6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide
isoenzyme hpalphaCA; isoenzyme hpbetaCA
6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV
6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide
isoenzyme gammaCA
6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide
isoenzyme mCA XIII
667-coumate
-
acetate
-
-
acetazolamide
-
strong inhibition
acetazolamide
about 70% inhibition at 1 mM
acetazolamide
-
at 0.5 mM inhibition of the cabonic anhydrase activity of the high molecular mass protein and stimulation of activity of the low molecular mass carrier in the PSII-membranes. At 0.5 mM acetazolamide moderately inhibits the carbonic anhydrase activity of PSI membranes
acetazolamide
-
62% residual activity at 1 mM
acetazolamide
-
100 mM, the firmly-membrane-associated activity is less sensitive to inhibition than the loosely-membrane associated enzyme
acetazolamide
-
uncompetitive inhibitor
acetazolamide
i.e. 5-acetamido-1,3,4-thiadiazole-2-sulfonamide
acetazolamide
-
complete inhibition above 0.01 mM
acetazolamide
Chaetoceros vixvisibilis
-
-
acetazolamide
-
noncompetitive reversible inhibitor
acetazolamide
binding structure analysis, overview. Each unit cell is comprised of four dimers of CrCAH3
acetazolamide
Coccomyxa sp.
-
0.001 mM , 50% inhibition
acetazolamide
sulfonamide CA inhibitor (CAI)
acetazolamide
-
at very low CO2 concentrations enzyme inhibition reduces photosynthesis
acetazolamide
-
i.e. 5-acetamido-1,3,4-thiadiazole-2-sulfonamide
acetazolamide
5-acetamido-1,3,4-thiadiazole-2-sulfonamide
acetazolamide
IC50: 97 nM
acetazolamide
Elephas trogontherii
-
cytosolic isoenzyme; inner peripheral isoenzyme; integral isoenzyme; outer peripheral isoenzyme
acetazolamide
-
carbonic anhydrase A is 100times less sensitive than carbonic anhydrase C; carbonic anhydrase A is completely inhibited at 1 mM, carbonic anhydrase C is completely inhibited at 0.01 mM
acetazolamide
-
inhibits CO2 hydration and esterase activity
acetazolamide
Halalkalibacterium halodurans
strong inhibition at 5 mM
acetazolamide
isoenzyme hpalphaCA; isoenzyme hpbetaCA
acetazolamide
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV
acetazolamide
-
i.e. 5-acetamido-1,3,4-thiadiazole-2-sulfonamide
acetazolamide
-
systemic carbonic anhydrase inhibitor
acetazolamide
promiscuous inhibitor of all isozymes except CA III
acetazolamide
AAZ, a sulfonamide inhibitor; AAZ, a sulfonamide inhibitor; AAZ, a sulfonamide inhibitor
acetazolamide
i.e. 5-acetamido-1,3,4-thiadiazole-2-sulfonamide; i.e. 5-acetamido-1,3,4-thiadiazole-2-sulfonamide; i.e. 5-acetamido-1,3,4-thiadiazole-2-sulfonamide
acetazolamide
-
isoenzyme I
acetazolamide
-
a non-membrane-permeable carbonic anhydrase inhibitor
acetazolamide
IC50: 0.4 mM
acetazolamide
isoenzyme gammaCA
acetazolamide
isoenzyme mCA XIII
acetazolamide
carbonic anhydrase XIII
acetazolamide
-
i.e. 5-acetamido-1,3,4-thiadiazole-2-sulfonamide
acetazolamide
-
effective, submicromolar inhibition
acetazolamide
the recombinant MgaCA shows a very similar acetazolamide inhibition features when compared to those of the native enzyme (MgaCA)
acetazolamide
-
increases carbonic anhydrase activity of photosystem 2 membranes at concentrations lower than 0.001 mM and suppresses this activity only at higher concentrations. Carbonic anhydrase activity of photosystem 1 membranes is suppressed
acetazolamide
5-acetamido-1,3,4-thiadiazole-2-sulfonamide, AAZ
acetazolamide
inhibits the CO2 hydrase activity of PgiCAb
acetazolamide
sulfonamide CA inhibitor (CAI)
acetazolamide
-
i.e. 5-acetamido-1,3,4-thiadiazole-2-sulfonamide
acetazolamide
-
shows effective carbonic anhydrase inhibitory activity
acetazolamide
highly inhibited by acetazolamide, i.e. 5-acetamido-1,3,4-thiadiazole-2-sulfonamide
acetazolamide
AZM, strong inhibitor
acetazolamide
-
at very low CO2 concentrations enzyme inhibition reduces photosynthesis
Ag+
-
weak inhibition
Ag+
-
competitive, strong inhibition of carbonic anhydrase esterase activity
Ag+
Halalkalibacterium halodurans
inhibits by 17% at 5 mM, no inhibition at 1 mM
Ag+
-
silver inhibits competitively
Ag+
-
uncompetitive inhibition
Ag+
-
uncompetitive inhibition
Al3+
-
competitive, very strong inhibition of carbonic anhydrase esterase activity
Al3+
Halalkalibacterium halodurans
inhibits by 12% at 5 mM, no inhibition at 1 mM
As3+
-
-
As3+
-
37.1% residual activity at 1 mM
azetazolamide
-
-
azide
about 30% inhibition at 1 mM
azide
weak inhibitor of the Zn(II)-substituted enzyme
azide
carbonic anhydrase XIII
azide
-
shows low micromolar inhibition against CA XV
B4O72-
-
benzene-1,2-diol
inhibition of isozyme hCA I
benzene-1,3-diol
inhibition of isozyme hCA I
benzene-1,3-disulfonamide
-
-
benzene-1,3-disulfonamide
-
benzene-1,3-disulfonamide
-
-
benzenesulfonamide
-
-
benzolamide
-
-
benzolamide
-
apical CAIV is inhibited by about 20% by 0.01 mM benzolamide
benzolamide
-
shows effective carbonic anhydrase inhibitory activity
benzylsulfonylsulfamic acid
-
-
benzylsulfonylsulfamic acid
-
-
bicarbonate
-
-
bicarbonate
-
is hypothesized to be an allosteric inhibitor of HICA
bicarbonate
-
high inhibition
bicarbonate
-
shows low micromolar inhibition against CA XV
bisulfite
-
-
Br-
-
-
Br-
weak, carbonic anhydrase XIII
brinzolamide
-
-
brinzolamide
O14939, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV catalytic domain
brinzolamide
-
potent inhibitor of isozymes CA II
brinzolamide
isoenzyme mCA XIII
brinzolamide
best isozyme CA XV inhibitor
brinzolamide
-
effective, submicromolar inhibition
brinzolamide
-
shows effective carbonic anhydrase inhibitory activity
bromide
-
-
bromide
-
strong inhibition
Ca2+
-
72% residual activity at 1 mM
Ca2+
-
25% inhibition at 0.2 mM
Ca2+
-
25% inhibition at 0.2 mM
Ca2+
-
25% inhibition at 0.2 mM
Ca2+
-
25% inhibition at 0.2 mM
Carbaryl
-
-
Carbonate
-
potent inhibitor
Carbonate
-
high inhibition
Carbonate
weak inhibitor of the Zn(II)-substituted enzyme, best inhibitor of the Co(II)-substituted enzyme
Carbonate
carbonic anhydrase XIII
Carbonate
-
best inhibitor
catechol
-
catechol
inhibition of isozyme hCA II
celecoxib
best CA 1 inhibitor
celecoxib
best isozyme CA XV inhibitor
celecoxib
-
shows effective carbonic anhydrase inhibitory activity
CF3SO2NH2
-
-
CF3SO3-
-
chlorazolamide
-
-
chloride
-
-
chlorzolamide
-
-
chlorzolamide
potent inhibitor
Cl-
-
10% residual activity at 1 mM
Cl-
-
100 mM, the firmly-membrane-associated activity is less sensitive to inhibition than the loosely-membrane associated enzyme
Cl-
-
relatively resistant to
Cl-
-
no significant inhibition at physiological concentrations
ClO4-
-
poor inhibition
CN-
-
KCN
CN-
-
i.e. cyanide, , isoenzyme I
CN-
best anion inhibitors for Zn2+-substituted enzyme are cyanate and hydrogen sulfide
CN-
-
anion inhibition of the esterase activity
CNO-
-
Co2+
-
weak inhibition
Co2+
Halalkalibacterium halodurans
inhibitits by 80-100% at 5 mM
Co2+
Halalkalibacterium halodurans
inhibits by 74% at 5 mM
Co2+
-
cobalt inhibits competitively
Co2+
-
competitive inhibition
Co2+
-
uncompetitive inhibition
CO32-
-
CS32-
-
Cu2+
-
weak inhibition
Cu2+
-
competitive, very strong inhibition of carbonic anhydrase esterase activity
Cu2+
Halalkalibacterium halodurans
inhibitits by 80-100% at 5 mM
Cu2+
Halalkalibacterium halodurans
inhibits completely at 5 mM, 66% inhibition at 1 mM
Cu2+
-
copper inhibits noncompetitively
Cu2+
-
uncompetitive inhibition
Cu2+
-
uncompetitive inhibition
curcumin
-
a competitive inhibitor with 4-nitrophenylacetate as substrate
Cyanate
-
-
Cyanate
-
high inhibition
Cyanate
best inhibitor of the Zn(II)-substituted enzyme
Cyanate
carbonic anhydrase XIII
Cyanate
-
weak inhibition
cyanide
-
potent inhibitor
cyanide
-
high inhibition
cyanide
carbonic anhydrase XIII
cyanide
-
shows low micromolar inhibition against CA XV
cyanide
-
weak inhibition
dehydroepiandrosterone sulfamate
-
-
dehydroepiandrosterone sulfamate
-
CA II inhibitor
dextran-bound acetazolamide
-
at very low CO2 concentrations enzyme inhibition reduces photosynthesis. Inhibition of enzyme reduces growth by about 10% at pH 8.4
-
dextran-bound acetazolamide
-
at very low CO2 concentrations enzyme inhibition reduces photosynthesis
-
dibenzyl N',N'''-(trichloro-lambda5-stibanediyl)biscarbamimidothioate
26.7% inhibition of CO2 hydration reaction after 30 min
dibenzyl N',N'''-(trichloro-lambda5-stibanediyl)biscarbamimidothioate
54.4% inhibition of CO2 hydration reaction after 30 min
dichlorophenamide
-
-
dichlorophenamide
-
systemic carbonic anhydrase inhibitor
dichlorophenamide
carbonic anhydrase XIII
dichlorophenamide
-
effective, submicromolar inhibition
dithiothreitol
-
10 mM. 22°C, 50% inactivation
dobutamin
-
a competitive inhibitor with 4-nitrophenylacetate as substrate
dorzolamide
-
-
dorzolamide
best CA 1 inhibitor
dorzolamide
O14939, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV catalytic domain
dorzolamide
-
potent inhibitor of isozymes CA II
dorzolamide
isoenzyme mCA XIII
dorzolamide
carbonic anhydrase XIII
dorzolamide
best isozyme CA XV inhibitor
dorzolamide
-
effective, submicromolar inhibition
dorzolamide
-
shows effective carbonic anhydrase inhibitory activity
DTT
50% inhibition at 0.5 mM, complete inhibition at above 2.5 mM
DTT
Halalkalibacterium halodurans
60% inhibition at 5 mM
EDTA
-
complete inhibition at 1 mM
EDTA
Halalkalibacterium halodurans
-
EDTA
-
71.49% residual activity at 1 mM
EMD 486019
EMD 486019 acts as a strong inhibitor of isozymes carbonic anhydrase II, VB, VII, IX, XII, and XIV
Et2NCS2-
-
ethanol
-
-
ethanol
-
carbonic anhydrase activity is significantly inhibited by 2ml/kg ethanol for up to 3 h following intraperitoneally administration
ethoxyzolamide
-
-
ethoxyzolamide
-
effectively suppresses the carbonic anhydrase activity of photosystem 2 membranes. Carbonic anhydrase activity of PS1 membranes is suppressed alike by both inhibitors
ethoxzolamide
-
-
ethoxzolamide
best CA 1 inhibitor
ethoxzolamide
isoenzyme hpalphaCA; isoenzyme hpbetaCA
ethoxzolamide
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV
ethoxzolamide
O14939, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV catalytic domain
ethoxzolamide
promiscuous inhibitor of all isozymes except CA III
ethoxzolamide
strong binding, U-shaped pH-dependence of the Gibbs energy of binding, the affinity is greatest in the near neutral pH region and diminished towards both the acidic and alkaline regions
ethoxzolamide
isoenzyme gammaCA
ethoxzolamide
isoenzyme mCA XIII
ethoxzolamide
best isozyme CA XV inhibitor
ethoxzolamide
-
effective, submicromolar inhibition
ethoxzolamide
-
shows effective carbonic anhydrase inhibitory activity
F-
-
-
F-
carbonic anhydrase XIII
Fe2+
Halalkalibacterium halodurans
inhibitits by 80-100% at 5 mM
Fe2+
Halalkalibacterium halodurans
inhibits completely at 5 mM, 74% inhibition at 1 mM
Fe2+
-
uncompetitive inhibition
Fe3+
Halalkalibacterium halodurans
inhibits completely at 5 mM, 75% inhibition at 1 mM
fluoride
-
-
FSO3-
-
Furosemide
-
-
Furosemide
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV
Furosemide
isoenzyme mCA XIII
H2NSO2NH2
-
H2NSO2NH2
isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA IX; isoenzyme hCA XII
H2NSO3H
-
H2NSO3H
isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA IX; isoenzyme hCA XII
HCO3-
-
7% residual activity at 1 mM
HCO3-
-
substrate inhibition above 0.1 M
Hg2+
-
complete inhibition at 1 mM
Hg2+
-
competitive, strong inhibition of carbonic anhydrase esterase activity
Hg2+
Halalkalibacterium halodurans
inhibitits by 80-100% at 5 mM
Hg2+
Halalkalibacterium halodurans
inhibits completely at 5 mM, 78% inhibition at 1 mM
Hg2+
-
uncompetitive inhibition
Hg2+
-
40.9% residual activity at 1 mM
homosulfanilamide
-
homosulfanilamide
carbonic anhydrase XIII
HS-
-
HS-
best anion inhibitors for Zn2+-substituted enzyme are cyanate and hydrogen sulfide
HSO3-
-
hydrochlorothiazide
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV
hydrochlorothiazide
isoenzyme mCA XIII
hydrogen carbonate
-
-
hydrogen sulfide
-
-
hydrogen sulfide
-
best Can2 anion inhibitor
hydrogen sulfide
best inhibitor
hydrogen sulfide
best inhibitor of the Zn(II)-substituted enzyme
hydrogen sulfide
carbonic anhydrase XIII
hydrogen sulfide
-
shows low micromolar inhibition against CA XV
hydrogen sulfite
-
-
hydrogen sulfite
weak inhibitor of the Zn(II)-substituted enzyme
hydrogen sulfite
-
shows low micromolar inhibition against CA XV
I-
-
KI; weak
I-
-
100 mM, the firmly-membrane-associated activity is less sensitive to inhibition than the loosely-membrane associated enzyme
I-
-
uncompetitive at pH 6.0, mixed type at higher pH-values
I-
-
inhibits 4-nitrophenyl acetate hydrolase activity
I-
-
relatively resistant to
I-
carbonic anhydrase XIII
imidazole
-
-
indisulam
-
indisulam
-
potent inhibitor of CA IX
indisulam
-
shows effective carbonic anhydrase inhibitory activity
Iodide
about 30% inhibition at 1 mM
Iodide
-
worst Can2 anion inhibitor
Iodide
-
strong inhibition
isocyanide
-
-
isopropylsulfonylsulfamic acid
-
-
isopropylsulfonylsulfamic acid
-
-
K+
-
25% inhibition at 0.2 mM
K+
-
25% inhibition at 0.2 mM
K+
-
25% inhibition at 0.2 mM
K+
-
25% inhibition at 0.2 mM
KSCN
-
uncompetitive inhibition of outer peripheral, cytosolic, inner peripheral and integral isoenzyme
KSCN
-
uncompetitive inhibitor
KSCN
Elephas trogontherii
-
cytosolic isoenzyme; inner peripheral isoenzyme; integral isoenzyme; outer peripheral isoenzyme
mafenide
-
-
methazolamide
-
-
methazolamide
-
systemic carbonic anhydrase inhibitor
methazolamide
promiscuous inhibitor of all isozymes except CA III
methazolamide
carbonic anhydrase XIII
methazolamide
best isozyme CA XV inhibitor
methazolamide
-
effective, submicromolar inhibition
methazolamide
-
shows effective carbonic anhydrase inhibitory activity
methylsulfonylsulfamic acid
-
-
methylsulfonylsulfamic acid
-
-
Mg2+
-
25% inhibition at 0.2 mM
Mg2+
-
25% inhibition at 0.2 mM
Mg2+
-
25% inhibition at 0.2 mM
Mg2+
-
25% inhibition at 0.2 mM
N'',N'''-Bis[(E)-(2,4-dichlorophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-Bis[(E)-(2,4-dichlorophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2,6-dichlorophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2,6-dichlorophenyl)methylidene]carbonic dihydrazide
mixed-type inhibition
N'',N'''-bis[(E)-(2-bromophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2-bromophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2-chloro-5-nitrophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2-chloro-5-nitrophenyl)methylidene]carbonic dihydrazide
mixed-type inhibition
N'',N'''-bis[(E)-(2-chlorophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2-chlorophenyl)methylidene]carbonic dihydrazide
mixed-type inhibition
N'',N'''-bis[(E)-(2-nitrophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(2-nitrophenyl)methylidene]carbonic dihydrazide
mixed-type inhibition
N'',N'''-bis[(E)-(4-bromophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(4-bromophenyl)methylidene]carbonic dihydrazide
mixed-type inhibition
N'',N'''-bis[(E)-(4-fluorophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(4-fluorophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(4-nitrophenyl)methylidene]carbonic dihydrazide
-
N'',N'''-bis[(E)-(4-nitrophenyl)methylidene]carbonic dihydrazide
mixed-type inhibition
N,N-dimethylamidimidodisulfuric acid
-
-
N,N-dimethylamidimidodisulfuric acid
-
-
N,N-dimethylimidodisulfuric diamide
-
-
N,N-dimethylimidodisulfuric diamide
-
-
N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
-
-
N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
-
-
N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
-
-
N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
-
-
N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
-
-
N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
-
-
N-(4-[(E)-[(aminosulfonyl)imino]methyl]phenyl)acetamide
-
-
N-(4-[(E)-[(aminosulfonyl)imino]methyl]phenyl)acetamide
-
-
N-(4-[[(aminosulfonyl)amino]sulfonyl]phenyl)acetamide
-
-
N-(4-[[(aminosulfonyl)amino]sulfonyl]phenyl)acetamide
-
-
N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)acetamide
-
-
N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)acetamide
-
-
N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)acetamide
-
specific inhibitor
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
-
-
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
-
-
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
-
-
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
-
-
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
-
-
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
-
-
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)furan-2-carboxamide
-
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)furan-2-carboxamide
-
-
N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide
-
-
N-(aminosulfonyl)-1,1,1-trichloromethanesulfonamide
-
-
N-(aminosulfonyl)-1,1,1-trichloromethanesulfonamide
-
-
N-(aminosulfonyl)-1,1,1-trifluoromethanesulfonamide
-
-
N-(aminosulfonyl)-1,1,1-trifluoromethanesulfonamide
-
-
N-(aminosulfonyl)-1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonamide
-
-
N-(aminosulfonyl)-1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonamide
-
-
N-(aminosulfonyl)-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide
-
-
N-(aminosulfonyl)-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide
-
-
N-(aminosulfonyl)-1-(7,7-dimethylbicyclo[2.2.1]hept-1-yl)methanesulfonamide
-
-
N-(aminosulfonyl)-1-(7,7-dimethylbicyclo[2.2.1]hept-1-yl)methanesulfonamide
-
-
N-(aminosulfonyl)-1-phenylmethanesulfonamide
-
-
N-(aminosulfonyl)-1-phenylmethanesulfonamide
-
-
N-(aminosulfonyl)-2,3,4,5,6-pentafluorobenzenesulfonamide
-
-
N-(aminosulfonyl)-2,3,4,5,6-pentafluorobenzenesulfonamide
-
-
N-(aminosulfonyl)-2,4,6-triisopropylbenzenesulfonamide
-
-
N-(aminosulfonyl)-2,4,6-triisopropylbenzenesulfonamide
-
-
N-(aminosulfonyl)-2,4,6-tripropylbenzenesulfonamide
-
-
N-(aminosulfonyl)-2,4,6-tripropylbenzenesulfonamide
-
-
N-(aminosulfonyl)-2,5-dichlorobenzenesulfonamide
-
-
N-(aminosulfonyl)-2,5-dichlorobenzenesulfonamide
-
-
N-(aminosulfonyl)-2-nitrobenzenesulfonamide
-
-
N-(aminosulfonyl)-2-nitrobenzenesulfonamide
-
-
N-(aminosulfonyl)-3,5-dichloro-2-hydroxybenzenesulfonamide
-
-
N-(aminosulfonyl)-3,5-dichloro-2-hydroxybenzenesulfonamide
-
-
N-(aminosulfonyl)-3-(trifluoromethyl)benzenesulfonamide
-
-
N-(aminosulfonyl)-3-(trifluoromethyl)benzenesulfonamide
-
-
N-(aminosulfonyl)-3-chloro-4-nitrobenzenesulfonamide
-
-
N-(aminosulfonyl)-3-chloro-4-nitrobenzenesulfonamide
-
-
N-(aminosulfonyl)-3-nitrobenzenesulfonamide
-
-
N-(aminosulfonyl)-3-nitrobenzenesulfonamide
-
-
N-(aminosulfonyl)-4-bromobenzenesulfonamide
-
-
N-(aminosulfonyl)-4-bromobenzenesulfonamide
-
-
N-(aminosulfonyl)-4-chlorobenzenesulfonamide
-
-
N-(aminosulfonyl)-4-chlorobenzenesulfonamide
-
-
N-(aminosulfonyl)-4-fluorobenzenesulfonamide
-
-
N-(aminosulfonyl)-4-fluorobenzenesulfonamide
-
-
N-(aminosulfonyl)-4-iodobenzenesulfonamide
-
-
N-(aminosulfonyl)-4-iodobenzenesulfonamide
-
-
N-(aminosulfonyl)-4-methoxybenzenesulfonamide
-
-
N-(aminosulfonyl)-4-methoxybenzenesulfonamide
-
-
N-(aminosulfonyl)-4-methylbenzenesulfonamide
-
-
N-(aminosulfonyl)-4-methylbenzenesulfonamide
-
-
N-(aminosulfonyl)-4-nitrobenzenesulfonamide
-
-
N-(aminosulfonyl)-4-nitrobenzenesulfonamide
-
-
N-(aminosulfonyl)-5-(dimethylamino)naphthalene-1-sulfonamide
-
-
N-(aminosulfonyl)-5-(dimethylamino)naphthalene-1-sulfonamide
-
-
N-(aminosulfonyl)benzenesulfonamide
-
-
N-(aminosulfonyl)benzenesulfonamide
-
-
N-(aminosulfonyl)methanesulfonamide
-
-
N-(aminosulfonyl)methanesulfonamide
-
-
N-(aminosulfonyl)naphthalene-1-sulfonamide
-
-
N-(aminosulfonyl)naphthalene-1-sulfonamide
-
-
N-(aminosulfonyl)naphthalene-2-sulfonamide
-
-
N-(aminosulfonyl)naphthalene-2-sulfonamide
-
-
N-(aminosulfonyl)propane-2-sulfonamide
-
-
N-(aminosulfonyl)propane-2-sulfonamide
-
-
N-(aminosulfonyl)quinoline-8-sulfonamide
-
-
N-(aminosulfonyl)quinoline-8-sulfonamide
-
-
N-(aminosulfonyl)thiophene-2-sulfonamide
-
-
N-(aminosulfonyl)thiophene-2-sulfonamide
-
-
N-4-methoxyphenylsulfonyl-N-2-nitrobenzyl-L-alanine hydroxamate
-
-
N-4-methoxyphenylsulfonyl-N-2-nitrobenzyl-L-alanine hydroxamate
-
-
N-4-methoxyphenylsulfonyl-N-benzyl-L-valine hydroxamate
-
-
N-4-methoxyphenylsulfonyl-N-benzyl-L-valine hydroxamate
-
-
n-hexanesulfonamide
-
-
N-hydroxysulfonamide
-
-
N-n-perfluorobutylsulfonyl-alanine hydroxamate
-
-
N-n-perfluorobutylsulfonyl-alanine hydroxamate
-
-
n-octanesulfonamide
-
-
n-octyl sulfamate
-
-
n-octyl sulfamate
-
inhibition of hCA I, hCA II, and hCA IX
N-pentafluorophenylsulfonyl-glycine
-
-
N-pentafluorophenylsulfonyl-glycine
-
-
N-pentafluorophenylsulfonyl-glycine hydroxamate
-
-
N-pentafluorophenylsulfonyl-glycine hydroxamate
-
-
N-pentafluorophenylsulfonyl-N-4-nitrobenzyl-glycine hydroxamate
-
-
N-pentafluorophenylsulfonyl-N-4-nitrobenzyl-glycine hydroxamate
-
-
N-salicylidene-sulfanilic acid amide
-
-
N-salicylidene-sulfanilic acid amide
-
-
N-salicylidene-sulfanilic acid amide cobalt acetate complex
-
-
N-salicylidene-sulfanilic acid amide cobalt acetate complex
-
-
N-salicylidene-sulfanilic acid amide cobalt chloride complex
-
-
N-salicylidene-sulfanilic acid amide cobalt chloride complex
-
-
N-salicylidene-sulfanilic acid amide cobalt nitrate complex
-
-
N-salicylidene-sulfanilic acid amide cobalt nitrate complex
-
-
N-salicylidene-sulfanilic acid amide cobalt sulfate complex
-
-
N-salicylidene-sulfanilic acid amide cobalt sulfate complex
-
-
N-salicylidene-sulfanilic acid amide copper chloride complex
-
-
N-salicylidene-sulfanilic acid amide copper chloride complex
-
-
N-salicylidene-sulfanilic acid amide copper nitrate complex
-
-
N-salicylidene-sulfanilic acid amide copper nitrate complex
-
-
N-salicylidene-sulfanilic acid amide nickel acetate complex
-
-
N-salicylidene-sulfanilic acid amide nickel acetate complex
-
-
N-salicylidene-sulfanilic acid amide nickel chloride complex
-
-
N-salicylidene-sulfanilic acid amide nickel chloride complex
-
-
N-salicylidene-sulfanilic acid amide nickel nitrate complex
-
-
N-salicylidene-sulfanilic acid amide nickel nitrate complex
-
-
N-salicylidene-sulfanilic acid amide nickel sulfate complex
-
-
N-salicylidene-sulfanilic acid amide nickel sulfate complex
-
-
N-[(1E)-(1-methyl-1H-pyrrol-2-yl)methylene]sulfamide
-
-
N-[(1E)-(1-methyl-1H-pyrrol-2-yl)methylene]sulfamide
-
-
N-[(1E)-(3,4,5-trimethoxyphenyl)methylene]sulfamide
-
-
N-[(1E)-(3,4,5-trimethoxyphenyl)methylene]sulfamide
-
-
N-[(1E)-(3-nitrophenyl)methylene]sulfamide
-
-
N-[(1E)-(3-nitrophenyl)methylene]sulfamide
-
-
N-[(1E)-(4-methoxyphenyl)methylene]sulfamide
-
-
N-[(1E)-(4-methoxyphenyl)methylene]sulfamide
-
-
N-[(1E)-(4-methylphenyl)methylene]sulfamide
-
-
N-[(1E)-(4-methylphenyl)methylene]sulfamide
-
-
N-[(1E)-(4-nitrophenyl)methylene]sulfamide
-
-
N-[(1E)-(4-nitrophenyl)methylene]sulfamide
-
-
N-[(1E)-(5-methylthien-2-yl)methylene]sulfamide
-
-
N-[(1E)-(5-methylthien-2-yl)methylene]sulfamide
-
-
N-[(1E)-phenylmethylene]sulfamide
-
-
N-[(1E)-phenylmethylene]sulfamide
-
-
N-[(1E)-thien-2-ylmethylene]sulfamide
-
-
N-[(1E)-thien-2-ylmethylene]sulfamide
-
-
N-[(1E)-[4-(dimethylamino)phenyl]methylene]sulfamide
-
-
N-[(1E)-[4-(dimethylamino)phenyl]methylene]sulfamide
-
-
N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
-
-
N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
-
-
N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
-
-
N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
-
-
N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
-
-
N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
-
-
N-[4-(aminosulfonyl)phenyl]-2,2,2-trifluoroacetamide
-
N-[4-(aminosulfonyl)phenyl]-2,2,2-trifluoroacetamide
-
-
N-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide
-
N-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide
-
-
N-[4-(aminosulfonyl)phenyl]-2-methylpropanamide
-
N-[4-(aminosulfonyl)phenyl]-2-methylpropanamide
-
-
N-[4-(aminosulfonyl)phenyl]acetamide
-
N-[4-(aminosulfonyl)phenyl]acetamide
-
-
N-[4-(aminosulfonyl)phenyl]benzamide
-
N-[4-(aminosulfonyl)phenyl]benzamide
-
-
N-[4-(aminosulfonyl)phenyl]butanamide
-
N-[4-(aminosulfonyl)phenyl]butanamide
-
-
N-[4-(aminosulfonyl)phenyl]pentanamide
-
N-[4-(aminosulfonyl)phenyl]pentanamide
-
-
N-[4-(aminosulfonyl)phenyl]propanamide
-
N-[4-(aminosulfonyl)phenyl]propanamide
-
-
N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
isoenzyme hpalphaCA; isoenzyme hpbetaCA
N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA III; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA XII; isoenzyme hCA XIV
N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
isoenzyme gammaCA
N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
isoenzyme mCA XIII
N3-
-
-
N3-
-
NaN3, uncompetitive at pH 6.0, mixed type at higher pH-values
N3-
-
anion inhibition of the esterase activity
Na+
-
25% inhibition at 0.2 mM
Na+
Halalkalibacterium halodurans
inhibits by 25% at 2 mM
Na+
-
25% inhibition at 0.2 mM
Na+
-
25% inhibition at 0.2 mM
Na+
-
25% inhibition at 0.2 mM
NaCl
-
-
NaCl
-
0.5 M, 60% inhibition
NaN3
-
uncompetitive inhibition of outer peripheral, cytosolic, inner peripheral and integral isoenzyme
NaN3
-
uncompetitive inhibitor
NaN3
Elephas trogontherii
-
cytosolic isoenzyme; inner peripheral isoenzyme; integral isoenzyme; outer peripheral isoenzyme
NCO-
-
-
NCO-
-
anion inhibition of the esterase activity
NH(SO3)22-
-
Ni2+
Halalkalibacterium halodurans
inhibitits by 80-100% at 5 mM
Ni2+
Halalkalibacterium halodurans
inhibits by 84% at 5 mM, 80% inhibition at 1 mM
nitrate
about 70% inhibition at 1 mM
nitrate
mutants M3 and M4 are more resistent against inhibition by nitrate compared to wild-type and mutants M1 and M2
nitrate
good inhibitor of the Co(II)-substituted enzyme
nitrate
weak, carbonic anhydrase XIII
nitrite
-
-
nitrite
weak inhibitor of the Zn(II)-substituted enzyme
nitrite
weak, carbonic anhydrase XIII
NO2-
-
41% residual activity at 1 mM
NO3-
-
36% residual activity at 1 mM
o-Iodosobenzoate
-
-
OCN-
-
i.e. cyanate, , KOCN
OCN-
-
i.e. cyanate, , KOCN
p-aminomethylbenzenesulfonamide
-
-
p-aminomethylbenzenesulfonamide
IC50: 0.0058 mM
p-toluenesulfonamide
-
-
P2O74-
-
Pb2+
-
33% residual activity at 1 mM
Pb2+
-
competitive, moderate inhibition of carbonic anhydrase esterase activity
Pb2+
Halalkalibacterium halodurans
inhibits by 30% at 5 mM
Pb2+
-
uncompetitive inhibition
Pb2+
-
46.6% residual activity at 1 mM
PCMB
-
-
PCMB
-
reversible with 5 mM dithiothreitol
PCMB
-
0.25 mM, complete inhibition after 10 min
perchlorate
-
-
perfluorobutanesulfonamide
-
-
perfluorobutanesulfonamide
-
-
PF6-
-
Ph-AsO3H2
-
Ph-B(OH)2
-
phenol
-
-
phenol
inhibition of isozyme hCA I; inhibition of isozyme hCA II
phenyl arsonic acid
-
weak Nce103 inhibitor
phenyl boronic acid
-
weak Nce103 inhibitor
phenyl sulfamate
-
-
phenylarsonic acid
-
-
phenylarsonic acid
weak inhibitor
phenylarsonic acid
carbonic anhydrase XIII
phenylboronic acid
-
-
phenylboronic acid
weak inhibitor
phenylboronic acid
carbonic anhydrase XIII
phenylboronic acid
-
weak inhibition
phenylsulfonylsulfamic acid
-
-
phenylsulfonylsulfamic acid
-
-
quinolin-8-ylsulfonylsulfamic acid
-
-
quinolin-8-ylsulfonylsulfamic acid
-
-
ReO4-
-
resorcinol
-
resorcinol
inhibition of isozyme hCA II
resveratrol
-
a competitive inhibitor with 4-nitrophenylacetate as substrate
RuO4-
-
S2O82-
-
saccharin
-
-
saccharin
-
shows effective carbonic anhydrase inhibitory activity
saccharin
-
effective STPCA inhibitor
salicylic acid
-
noncompetitive inhibition of isozymes carbonic anhydrase I and II
SCN-
-
KSCN, weak
SCN-
-
inhibits 4-nitrophenyl acetate hydrolase activity
SCN-
-
anion inhibition of the esterase activity
SDS
-
-
SDS
Halalkalibacterium halodurans
-
SDS
the wild-type enzyme is inactivated at 0.4% w/v, the mutant enzymes are more stable showing residual activity at that concentration
SeCN-
-
SeO42-
-
SnO32-
-
SO42-
-
-
SO42-
isoenzyme hCA I; isoenzyme hCA XII
sulfamate
-
-
sulfamate
-
best inhibitor
sulfamic acid
-
-
sulfamic acid
-
weak inhibitor
sulfamic acid
weak, carbonic anhydrase XIII
sulfamide
-
-
sulfamide
-
high inhibition
sulfamide
-
strong inhibition
sulfanilamide
about 70% inhibition at 1 mM
sulfanilamide
-
uncompetitive inhibition of outer peripheral, cytosolic, inner peripheral and integral isoenzyme
sulfanilamide
-
uncompetitive inhibitor
sulfanilamide
quite weak CA 1 inhibitor
sulfanilamide
-
noncompetitive reversible inhibitor
sulfanilamide
Elephas trogontherii
-
integral isoenzyme; outer peripheral isoenzyme
sulfanilamide
-
noncompetitive
sulfate
-
-
sulfate
-
weak Nce103 inhibitor
sulfate
-
shows low micromolar inhibition against CA XV
sulfate
-
slight inhibition
sulfonamide
-
-
sulphanilamide
-
strong inhibition
sulphanilamide
Elephas trogontherii
-
cytosolic isoenzyme; inner peripheral isoenzyme
sulpiride
best CA 1 inhibitor
sulpiride
-
shows effective carbonic anhydrase inhibitory activity
sulthiame
-
-
sulthiame
isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XIV
sulthiame
isoenzyme mCA XIII
sulthiame
best isozyme CA XV inhibitor
sulthiame
-
shows effective carbonic anhydrase inhibitory activity
TeO42-
-
tert-butyl 3-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate
-
-
tert-butyl 3-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate
-
-
tert-butyl 4-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate
-
-
tert-butyl 4-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate
-
-
tert-butyl 5-[[(aminosulfonyl)amino]sulfonyl]-2-hydroperoxyphenylcarbamate
-
-
tert-butyl 5-[[(aminosulfonyl)amino]sulfonyl]-2-hydroperoxyphenylcarbamate
-
-
thien-2-ylsulfonylsulfamic acid
-
-
thien-2-ylsulfonylsulfamic acid
-
-
thiocyanate
-
-
thiocyanate
best inhibitor
thiocyanate
-
high inhibition
thiocyanate
weak inhibitor of the Zn(II)-substituted enzyme
thiocyanate
carbonic anhydrase XIII
thiocyanate
-
shows low micromolar inhibition against CA XV
thiocyanate
-
weak inhibition
Thiocyanide
-
-
topiramate
-
topiramate
isoenzyme hpalphaCA; isoenzyme hpbetaCA
topiramate
O43570, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV
topiramate
-
powerful inhibitor of CA II
topiramate
isoenzyme gammaCA
topiramate
isoenzyme mCA XIII
topiramate
-
shows effective carbonic anhydrase inhibitory activity
V2O74-
-
valdecoxib
best CA 1 inhibitor
valdecoxib
carbonic anhydrase XIII
valdecoxib
-
shows effective carbonic anhydrase inhibitory activity
Zn2+
-
weak inhibition
Zn2+
-
competitive, strong inhibition of carbonic anhydrase esterase activity
Zn2+
Halalkalibacterium halodurans
inhibits by 95% at 5 mM
Zn2+
-
the enzyme binds three catalytic Zn2+ ions at symmetry-related subunit interfaces. Zinc binding drives the folding and association of the homotrimeric enzyme
Zn2+
-
zinc inhibits uncompetitively
Zn2+
-
competitive inhibition
zonisamide
-
zonisamide
O14939, P00915, P00918, P07451, P22748, P23280, P35218, P43166, Q16790, Q9ULX7, Q9Y2D0 isoenzyme hCA I; isoenzyme hCA II; isoenzyme hCA III; isoenzyme hCA IV; isoenzyme hCA IX; isoenzyme hCA VA; isoenzyme hCA VB; isoenzyme hCA VI; isoenzyme hCA VII; isoenzyme hCA XII; isoenzyme hCA XIV catalytic domain
zonisamide
isoenzyme mCA XIII
zonisamide
-
effective, submicromolar inhibition
zonisamide
-
shows effective carbonic anhydrase inhibitory activity
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
-
-
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
-
-
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
-
-
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
-
-
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
-
-
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
-
-
[(7,7-dimethylbicyclo[2.2.1]hept-1-yl)methyl]sulfonylsulfamic acid
-
-
[(7,7-dimethylbicyclo[2.2.1]hept-1-yl)methyl]sulfonylsulfamic acid
-
-
[3-(trifluoromethyl)phenyl]sulfonylsulfamic acid
-
-
[3-(trifluoromethyl)phenyl]sulfonylsulfamic acid
-
-
[3-[(tert-butoxycarbonyl)amino]-4-hydroperoxyphenyl]sulfonylsulfamic acid
-
-
[3-[(tert-butoxycarbonyl)amino]-4-hydroperoxyphenyl]sulfonylsulfamic acid
-
-
[3-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic acid
-
-
[3-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic acid
-
-
[4-(acetylamino)phenyl]sulfonylsulfamic acid
-
-
[4-(acetylamino)phenyl]sulfonylsulfamic acid
-
-
[4-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic acid
-
-
[4-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic acid
-
-
[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]hydrazine
-
[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]hydrazine
-
-
[5-(dimethylamino)-1-naphthyl]sulfonylsulfamic acid
-
-
[5-(dimethylamino)-1-naphthyl]sulfonylsulfamic acid
-
-
[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic acid
-
-
[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic acid
-
-
[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic amide
-
-
[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic amide
-
-
[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic acid
-
-
[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic acid
-
-
[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic amide
-
-
[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic amide
-
-
[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic acid
-
-
[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic acid
-
-
[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic amide
-
-
[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic amide
-
-
[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic acid
-
-
[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic acid
-
-
[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic amide
-
-
[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic amide
-
-
additional information
-
dianionic inhibitors depress the rate of H+ transfer during turnover by stabilizing the protonated from of Lys64
-
additional information
carbohydrazones as another class of carbonic anhydrase inhibitors, synthesis, kinetics, and ligand docking studies, overview. Single crystal X-ray diffraction, structural coordinates of bovine carbonic anhydrase (PDB ID 1V9E) is used for docking of carbohydrazone compounds, three-dimensional structure analysis. No inhibition by N'',N'''-bis[(E)-(4-chlorophenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(2-fluorophenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-phenylmethylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(2-hydroxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(3-hydroxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(4-hydroxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(2,3-dihydroxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(2,5-dihydroxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(5-bromo-2-hydroxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(2,4,6-trihydroxyphenyl)methylidene]carbonicdihydrazide, N'',N'''-bis[(E)-(2,3,4-trihydroxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(2-methoxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(3-methoxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(4-methoxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(2-hydroxy-5-methoxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(2-hydroxy-3-methoxyphenyl)methylidene]carbonic dihydrazide, N'',N'''-bis[(E)-(3-ethoxy-2-hydroxyphenyl)methylidene]carbonic dihydrazide, and N'',N'''-bis[(E)-(3,4-dimethoxyphenyl)methylidene]carbonic dihydrazide
-
additional information
antimony(III) complexes inhibit alpha-carbonic anhydrase isozyme II from bovine erythrocytes. No inhibition by 5
-
additional information
best bsCA II inhibitors are some glycosylated sulfanilamides, aliphatic sulfamates, and halogenated sulfanilamides
-
additional information
-
best bsCA II inhibitors are some glycosylated sulfanilamides, aliphatic sulfamates, and halogenated sulfanilamides
-
additional information
-
perchlorate is not an inhibitor in concentrations up to 200 mM
-
additional information
perchlorate, tetrafluoroborate, azide, fluoride, and bromide are not inhibitory for the enzyme
-
additional information
-
perchlorate, tetrafluoroborate, azide, fluoride, and bromide are not inhibitory for the enzyme
-
additional information
-
Can2 is not inhibited by perchlorate
-
additional information
-
the inhibitory metals might be dangerous at low micromolar concentrations for fish carbonic anhydrase enzymes
-
additional information
-
sulfate, sulfide, azide, nitrate, nitrite and iodide exhibit strong inhibitory activity in the micromolar range (Ki values of 5.5-15.5 mM). Cyanide, bromide, chloride, and carbonate are moderate inhibitors, whereas other anions show only weak activities. The anions inhibit enzyme HmCA in a similar manner to other alpha-CAs from mammals, but the susceptibility to various anions differs significantly between the Halomonas sp. and other organism CAs, overview
-
additional information
-
insensitive to bromopyruvate
-
additional information
-
overview
-
additional information
overview
-
additional information
-
NaClO4 is not inhibitory
-
additional information
-
not inhibited by acetazolamide
-
additional information
no inhibition of HCA II by citrate and no conformational changes of amino-acid side chains as a result of the use of citrate at pH 6.0-11.0
-
additional information
-
no inhibition of HCA II by citrate and no conformational changes of amino-acid side chains as a result of the use of citrate at pH 6.0-11.0
-
additional information
-
synthesis of two series of disubstituted coumarins incorporating ether and acetyl/propionyl moieties in positions 6,7 and 7,8 of the heterocyclic ring. The compounds are very weak or ineffective as inhibitors of the housekeeping, offtarget isozymes CA I and CA II. The 6,7-disubstituted series show ineffective inhibition also for the transmembrane tumor-associated isoforms CA IX and XII, whereas the corresponding isomeric 7,8-disubstituted coumarins show nanomolar/subnanomolar inhibition of CA IX/XII, overview. No inhibition by 12 and 13
-
additional information
-
N-beta-glycosyl sulfamides are selective inhibitors of the cancer-associated carbonic anhydrase isoforms IX and XII
-
additional information
-
development and synthesis of a series of compounds incorporating regioisomeric phenylethynylbenzenesulfonamide moieties, analysis of potential as inhibitors of the four human isozymes, hCA I, hCA II, hCA IX, and hCA XII. The position of the sulfamoyl group with respect to the alkyne functionality, and the nature of the moieties substituting the second aromatic ring are the principal structural features influencing CA inhibition. The para-sulfamoyl-substituted derivatives are effective inhibitors of CA IX and XII, the meta-substituted regioisomers of CA I, X and XII, whereas the ortho-substituted sulfonamides ae weak inhibitors of CA I, II and IX, but inhibit ignificantly CA XII, structure-activity relationship study, overview
-
additional information
-
carbonic anhydrases are inhibited by sulfonamides, inorganic anions, phenols, coumarins (acting as prodrugs) and polyamines. Development of hydroxy-, methoxy-substituted benzoic acids as well as di-, tri-methoxy benzenes as submicromolar-low micromolar inhibitors of carbonic anhydrase isozymes, molecular docking and inhibition mechanism, overview
-
additional information
-
synthesis of 2-[(p-toluenesulfonamido)-N-yl]-l,3,4-thiadiazole-5-sulfonamide inhibitors, inhibitory potencies versus isozymes CAII, docking study, overview
-
additional information
-
an additional 3-fluoro substituent on the 4-amino-benzenesulfonamide scaffold of inhibitors alters the inhibition profiles against the cytosolic isozymes hCA I, II, III, VII and XIII, interaction analysis, overview. The binding differences render the inhibitors more isozyme-specific. Docking studies, overview
-
additional information
-
some natural phenols show effective hCA II inhibitory effects, in the same range as the clinically used sulfonamide acetazolamide, and might be used as leads for generating enzyme inhibitors possibly targeting other CA isozymes
-
additional information
presence of D2O reduces catalysis, but does not change how it proceeds; presence of D2O reduces catalysis, but does not change how it proceeds
-
additional information
presence of D2O reduces catalysis, but does not change how it proceeds; presence of D2O reduces catalysis, but does not change how it proceeds
-
additional information
-
presence of D2O reduces catalysis, but does not change how it proceeds; presence of D2O reduces catalysis, but does not change how it proceeds
-
additional information
structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, in silico modeling of inhibitors in CA I, oveview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview
-
additional information
structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, in silico modeling of inhibitors in CA I, oveview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview
-
additional information
structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, in silico modeling of inhibitors in CA I, oveview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview
-
additional information
structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, in silico modeling of inhibitors in CA I, oveview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview; structure-activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity, inhibition of different human isozymes, overview
-
additional information
2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview
-
additional information
2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview
-
additional information
2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview
-
additional information
2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview
-
additional information
-
2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview; 2-benzylpiperazine is a scaffold for potent human carbonic anhydrase inhibitors, compounds synthesis, enzyme inhibition, and enantioselectivity, overview
-
additional information
isozyme hCA II is inhibited by flavonoids, poor inhibition by pelargonin; isozyme hCA I is inhibited by flavonoids, poor inhibition by pelargonin
-
additional information
isozyme hCA II is inhibited by flavonoids, poor inhibition by pelargonin; isozyme hCA I is inhibited by flavonoids, poor inhibition by pelargonin
-
additional information
-
isozyme hCA II is inhibited by flavonoids, poor inhibition by pelargonin; isozyme hCA I is inhibited by flavonoids, poor inhibition by pelargonin
-
additional information
3-[[(3,4-dimethoxyphenyl)methyl]amino]-2,5,6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide does not exhibit selectivity for CA XIV
-
additional information
-
3-[[(3,4-dimethoxyphenyl)methyl]amino]-2,5,6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide does not exhibit selectivity for CA XIV
-
additional information
inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 2FW4, modeling; inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 3IAI, modeling. No inhibition by pyrogallol; inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 5AML, modeling
-
additional information
inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 2FW4, modeling; inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 3IAI, modeling. No inhibition by pyrogallol; inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 5AML, modeling
-
additional information
inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 2FW4, modeling; inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 3IAI, modeling. No inhibition by pyrogallol; inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 5AML, modeling
-
additional information
-
inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 2FW4, modeling; inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 3IAI, modeling. No inhibition by pyrogallol; inhibitor synthesis and isozyme in silico docking study using enzyme structure, PDB ID 5AML, modeling
-
additional information
benzothiazole derivative inhibitor synthesis, overview; benzothiazole derivative inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, (S)-benzyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate; benzothiazole derivative inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate; inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, (S)-benzyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate
-
additional information
benzothiazole derivative inhibitor synthesis, overview; benzothiazole derivative inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, (S)-benzyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate; benzothiazole derivative inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate; inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, (S)-benzyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate
-
additional information
benzothiazole derivative inhibitor synthesis, overview; benzothiazole derivative inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, (S)-benzyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate; benzothiazole derivative inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate; inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, (S)-benzyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate
-
additional information
benzothiazole derivative inhibitor synthesis, overview; benzothiazole derivative inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, (S)-benzyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate; benzothiazole derivative inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate; inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, (S)-benzyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate
-
additional information
-
benzothiazole derivative inhibitor synthesis, overview; benzothiazole derivative inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, (S)-benzyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate; benzothiazole derivative inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate; inhibitor synthesis, overview. No inhibition by benzyl (2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, (S)-tert-butyl (1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate, (S)-benzyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, benzyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, tert-butyl (2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, (S)-benzyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, (S)-tert-butyl (1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, and (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium di-2,2,2-trifluoroacetate
-
additional information
some uracil derivatives have carbonic anhydrase inhibitory properties, overview; some uracil derivatives have carbonic anhydrase inhibitory properties, overview
-
additional information
some uracil derivatives have carbonic anhydrase inhibitory properties, overview; some uracil derivatives have carbonic anhydrase inhibitory properties, overview
-
additional information
-
some uracil derivatives have carbonic anhydrase inhibitory properties, overview; some uracil derivatives have carbonic anhydrase inhibitory properties, overview
-
additional information
synthesis, X-ray structure, in silico calculation, and carbonic anhydrase inhibitory properties of benzylimidazole metal complexes, i.e. three coordination compounds of formula [M(bmim)2Cl2], crystal structures of metal complexes, overview. Each complex incorporates 1-benzyl-2-methylimidazole (bmim) as ligand. The coordination polyhedron around the metal center for all complexes has a quasi-regular tetragonal geometry. In the 1-benzyl-2-methylimidazole ligand, imidazole moiety is connected to phenyl cycle via a methylene linker. Density functional theory calculations are carried out on the title compounds, with Co2+, Zn2+, and Hg2+, and as well on hypothetical complexes (with Cu2+, Ni2+) in order to elucidate their electronic and molecular structure. All three complxes do not inhibit the enzyme significantly; synthesis, X-ray structure, in silico calculation, and carbonic anhydrase inhibitory properties of benzylimidazole metal complexes, i.e. three coordination compounds of formula [M(bmim)2Cl2], crystal structures of metal complexes, overview. Each complex incorporates 1-benzyl-2-methylimidazole (bmim) as ligand. The coordination polyhedron around the metal center for all complexes has a quasi-regular tetragonal geometry. In the 1-benzyl-2-methylimidazole ligand, imidazole moiety is connected to phenyl cycle via a methylene linker. Density functional theory calculations are carried out on the title compounds, with Co2+, Zn2+, and Hg2+, and as well on hypothetical complexes (with Cu2+, Ni2+) in order to elucidate their electronic and molecular structure. Only compound [Hg(bmim)2Cl2] exhibits a modest inhibitory effect against enzyme hCA I, probably due to the affinity of Hg(II) for His residues at the entrance of the active site cavity
-
additional information
synthesis, X-ray structure, in silico calculation, and carbonic anhydrase inhibitory properties of benzylimidazole metal complexes, i.e. three coordination compounds of formula [M(bmim)2Cl2], crystal structures of metal complexes, overview. Each complex incorporates 1-benzyl-2-methylimidazole (bmim) as ligand. The coordination polyhedron around the metal center for all complexes has a quasi-regular tetragonal geometry. In the 1-benzyl-2-methylimidazole ligand, imidazole moiety is connected to phenyl cycle via a methylene linker. Density functional theory calculations are carried out on the title compounds, with Co2+, Zn2+, and Hg2+, and as well on hypothetical complexes (with Cu2+, Ni2+) in order to elucidate their electronic and molecular structure. All three complxes do not inhibit the enzyme significantly; synthesis, X-ray structure, in silico calculation, and carbonic anhydrase inhibitory properties of benzylimidazole metal complexes, i.e. three coordination compounds of formula [M(bmim)2Cl2], crystal structures of metal complexes, overview. Each complex incorporates 1-benzyl-2-methylimidazole (bmim) as ligand. The coordination polyhedron around the metal center for all complexes has a quasi-regular tetragonal geometry. In the 1-benzyl-2-methylimidazole ligand, imidazole moiety is connected to phenyl cycle via a methylene linker. Density functional theory calculations are carried out on the title compounds, with Co2+, Zn2+, and Hg2+, and as well on hypothetical complexes (with Cu2+, Ni2+) in order to elucidate their electronic and molecular structure. Only compound [Hg(bmim)2Cl2] exhibits a modest inhibitory effect against enzyme hCA I, probably due to the affinity of Hg(II) for His residues at the entrance of the active site cavity
-
additional information
development and synthesis of a class of CA IX inhibitors that comprise a sulfamate as the zinc binding group, a variable linker, and a carbohydrate tail moiety
-
additional information
-
no inhibition by perchlorate
-
additional information
-
fluoride, chloride, and sulfate do not inhibit the Zn2+-substituted enzyme and the Co2+-substituted enzyme appreciably; Zn(II)- and Co(II)-substituted enzymes show a very different behavior against anion inhibitors.The best Zn-Cam anion inhibitors are hydrogen sulfide and cyanate whereas thiocyanate, azide, carbonate, nitrite, and hydrogensulfite are weaker inhibitors. The inhibition of the Zn(II)-substituted enzyme by sulfide is puzzling since Cam is proposed to be located outside the cytoplasmic membrane where it is exposed to high levels of sulfide in the anaerobic environments. The best inhibitors of the Co(II)-substituted enzyme is carbonate, followed by nitrate and hydrogencarbonate. Fluoride, chloride, and sulfate do not inhibit either Zn(II)- or Co(II)-substituted enzyme appreciably up to concentrations of 200 mM. This lack of inhibition may represent an adaptation to marine environments high in chloride and sulfate
-
additional information
fluoride, chloride, and sulfate do not inhibit the Zn2+-substituted enzyme and the Co2+-substituted enzyme appreciably; Zn(II)- and Co(II)-substituted enzymes show a very different behavior against anion inhibitors.The best Zn-Cam anion inhibitors are hydrogen sulfide and cyanate whereas thiocyanate, azide, carbonate, nitrite, and hydrogensulfite are weaker inhibitors. The inhibition of the Zn(II)-substituted enzyme by sulfide is puzzling since Cam is proposed to be located outside the cytoplasmic membrane where it is exposed to high levels of sulfide in the anaerobic environments. The best inhibitors of the Co(II)-substituted enzyme is carbonate, followed by nitrate and hydrogencarbonate. Fluoride, chloride, and sulfate do not inhibit either Zn(II)- or Co(II)-substituted enzyme appreciably up to concentrations of 200 mM. This lack of inhibition may represent an adaptation to marine environments high in chloride and sulfate
-
additional information
-
fluoride, chloride, and sulfate do not inhibit the enzyme appreciably
-
additional information
-
overview
-
additional information
overview
-
additional information
-
isoform CA XV is not inhibited by tetrafluoroborate
-
additional information
inhibitor molecular docking simulations using the three-dimensional structure of the thiocyanate-bound Mtb Rv1248 enzyme, PDB ID 1YLK, binding structures, overview; inhibitor molecular docking simulations using the three-dimensional structure of the thiocyanate-bound Mtb Rv3588c enzyme, PDB ID 2A5V, binding structures, overview
-
additional information
-
inhibitor molecular docking simulations using the three-dimensional structure of the thiocyanate-bound Mtb Rv1248 enzyme, PDB ID 1YLK, binding structures, overview; inhibitor molecular docking simulations using the three-dimensional structure of the thiocyanate-bound Mtb Rv3588c enzyme, PDB ID 2A5V, binding structures, overview
-
additional information
-
fluoride, sulfate, perchlorate and tetrafluoroborate do not inhibit appreciably NcoCA, whereas the other halides, pseudohalides, bicarbonate, nitrate, nitrite and many complex inorganic anions cause inhibition in the millimolar range
-
additional information
-
the epipodites and antennal gland display decreased levels of mRNA expression and stable enzyme activity at 24 h after hypo-osmotic stress
-
additional information
antimony(III) complexes inhibit glutathione reductase activity of chloroplast, and a number of them also exhibit good inhibitory efficiency against the photosynthetic and carbonic anhydrase activity of Pisum sativum photosystem II
-
additional information
-
not inhibited by quinine, qinghausu, and chloroquine
-
additional information
sulfonamides CA inhibitors generally show much weaker inhibitory activity against PfCAdom compared to truncated PfCA
-
additional information
-
sulfonamides CA inhibitors generally show much weaker inhibitory activity against PfCAdom compared to truncated PfCA
-
additional information
no inhibition by fluoride, iodide, chloride, azide, sulfate, P2O74-, V2O74-, ReO4-, chlorate, tetrafluoroborate, PF6-, and CF3SO3-
-
additional information
-
not inhibited by perchlorate
-
additional information
-
bromide, iodide and sulfamide, are the best anion inhibitors, with Ki values of 0.0087-0.0108 mM. Benzenesulfonamides substituted in 2-, 4- and 3,4-positions with amino, alkyl, halogeno and hydroxyalkyl moieties have Ki values in the range of 0.000976-0.01845 mM. Better inhibition with Ki values in the range of 154-654 nM is observed for benzenesulfonamides incorporating aminoalkyl/carboxyalkyl moieties or halogenosulfanilamides, benzene-1,3-disulfonamides, simple heterocyclic sulfonamides and sulfanilyl-sulfonamides. The clinically used sulfonamides/sulfamates, e.g. acetazolamide, ethoxzolamide, methazolamide, dorzolamide, topiramate, celecoxib, generally show effective scCA inhibitory activity, with Ki values in the range of 82.6-133 nM, overview
-
additional information
-
strongest inhibitors of enzyme CA are aromatic or heteroaromatic sulfonamides
-
additional information
the C-terminal tail appears to partly inhibit activity, possibly indicating a role in minimizing the activity of unencapsulated enzyme
-